Title: Full Text of SB1390
Official Title: 
Number of Sections: 1
Source: versions - Senate Amendment 001
Media Type: text/html

================================================================================

Section 1:
Full Text of SB1390 ILGA.GOV SB1390 - 104th General Assembly Sen. David KoehlerFiled: 3/17/2025   10400SB1390sam001LRB104 08735 BAB 23976 a1AMENDMENT TO SENATE BILL 13902    AMENDMENT NO. ______. Amend Senate Bill 1390 by replacing 3everything after the enacting clause with the following: 4    "Section 1. This Act may be referred to as the 5Prescription Drug Affordability Act. 6    Section 5. The State Employees Group Insurance Act of 1971 7is amended by changing Section 6.11 as follows: 8    (5 ILCS 375/6.11)9    Sec. 6.11. Required health benefits; Illinois Insurance 10Code requirements. The program of health benefits shall 11provide the post-mastectomy care benefits required to be 12covered by a policy of accident and health insurance under 13Section 356t of the Illinois Insurance Code. The program of 14health benefits shall provide the coverage required under 15Sections 356g, 356g.5, 356g.5-1, 356m, 356q, 356u, 356u.10,   10400SB1390sam001- 2 -LRB104 08735 BAB 23976 a1356w, 356x, 356z.2, 356z.4, 356z.4a, 356z.5, 356z.6, 356z.8, 2356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 3356z.17, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 4356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 5356z.51, 356z.53, 356z.54, 356z.55, 356z.56, 356z.57, 356z.59, 6356z.60, 356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 7356z.70, and 356z.71, 356z.74, 356z.76, and 356z.77 of the 8Illinois Insurance Code. The program of health benefits must 9comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and 10370c.1 and Article XXXIIB of the Illinois Insurance Code. The 11program of health benefits shall provide the coverage required 12under Section 356m of the Illinois Insurance Code and, for the 13employees of the State Employee Group Insurance Program only, 14the coverage as also provided in Section 6.11B of this Act. The 15Department of Insurance shall enforce the requirements of this 16Section with respect to Sections 370c and 370c.1 and Article 17XXXIIB of the Illinois Insurance Code; all other requirements 18of this Section shall be enforced by the Department of Central 19Management Services.20    Rulemaking authority to implement Public Act 95-1045, if 21any, is conditioned on the rules being adopted in accordance 22with all provisions of the Illinois Administrative Procedure 23Act and all rules and procedures of the Joint Committee on 24Administrative Rules; any purported rule not so adopted, for 25whatever reason, is unauthorized. 26(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22;   10400SB1390sam001- 3 -LRB104 08735 BAB 23976 a1102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 21-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-768, 3eff. 1-1-24; 102-804, eff. 1-1-23; 102-813, eff. 5-13-22; 4102-816, eff. 1-1-23; 102-860, eff. 1-1-23; 102-1093, eff. 51-1-23; 102-1117, eff. 1-13-23; 103-8, eff. 1-1-24; 103-84, 6eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, eff. 1-1-24; 7103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 103-551, eff. 88-11-23; 103-605, eff. 7-1-24; 103-718, eff. 7-19-24; 103-751, 9eff. 8-2-24; 103-870, eff. 1-1-25; 103-914, eff. 1-1-25; 10103-918, eff. 1-1-25; 103-951, eff. 1-1-25; 103-1024, eff. 111-1-25; revised 11-26-24.) 12    Section 10. The School Code is amended by changing Section 1310-22.3f as follows: 14    (105 ILCS 5/10-22.3f)15    Sec. 10-22.3f. Required health benefits. Insurance 16protection and benefits for employees shall provide the 17post-mastectomy care benefits required to be covered by a 18policy of accident and health insurance under Section 356t and 19the coverage required under Sections 356g, 356g.5, 356g.5-1, 20356m, 356q, 356u, 356u.10, 356w, 356x, 356z.4, 356z.4a, 21356z.6, 356z.8, 356z.9, 356z.11, 356z.12, 356z.13, 356z.14, 22356z.15, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 23356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 24356z.51, 356z.53, 356z.54, 356z.56, 356z.57, 356z.59, 356z.60,   10400SB1390sam001- 4 -LRB104 08735 BAB 23976 a1356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 356z.70, and 2356z.71, 356z.74, and 356z.77 of the Illinois Insurance Code. 3Insurance policies shall comply with Section 356z.19 of the 4Illinois Insurance Code. The coverage shall comply with 5Sections 155.22a, 355b, and 370c and Article XXXIIB of the 6Illinois Insurance Code. The Department of Insurance shall 7enforce the requirements of this Section. 8    Rulemaking authority to implement Public Act 95-1045, if 9any, is conditioned on the rules being adopted in accordance 10with all provisions of the Illinois Administrative Procedure 11Act and all rules and procedures of the Joint Committee on 12Administrative Rules; any purported rule not so adopted, for 13whatever reason, is unauthorized. 14(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 15102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 161-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-804, 17eff. 1-1-23; 102-813, eff. 5-13-22; 102-816, eff. 1-1-23; 18102-860, eff. 1-1-23; 102-1093, eff. 1-1-23; 102-1117, eff. 191-13-23; 103-84, eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, 20eff. 1-1-24; 103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 21103-551, eff. 8-11-23; 103-605, eff. 7-1-24; 103-718, eff. 227-19-24; 103-751, eff. 8-2-24; 103-914, eff. 1-1-25; 103-918, 23eff. 1-1-25; 103-1024, eff. 1-1-25; revised 11-26-24.) 24    Section 15. The Illinois Insurance Code is amended by 25changing Sections 513b1 and 513b3 and by adding Section   10400SB1390sam001- 5 -LRB104 08735 BAB 23976 a1513b1.1 as follows: 2    (215 ILCS 5/513b1)3    Sec. 513b1. Pharmacy benefit manager contracts.4    (a) As used in this Section: 5    "340B drug discount program" means the program established 6under Section 340B of the federal Public Health Service Act, 742 U.S.C. 256b. 8    "340B entity" means a covered entity as defined in 42 9U.S.C. 256b(a)(4) authorized to participate in the 340B drug 10discount program. 11    "340B pharmacy" means any pharmacy used to dispense 340B 12drugs for a covered entity, whether entity-owned or external.13    "Affiliate" means a person or entity that directly or 14indirectly through one or more intermediaries controls or is 15controlled by, or is under common control with, the person or 16entity specified.17    "Biological product" has the meaning ascribed to that term 18in Section 19.5 of the Pharmacy Practice Act.19    "Brand name drug" means a drug that has been approved 20under 42 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 21marketed, sold, or distributed under a proprietary, 22trademark-protected name.23    "Complex or chronic medical condition" means a physical, 24behavioral, or developmental condition that has no known cure, 25is progressive, or can be debilitating or fatal if unmanaged   10400SB1390sam001- 6 -LRB104 08735 BAB 23976 a1or untreated.2    "Covered individual" means a member, participant, 3enrollee, contract holder, policyholder, or beneficiary of a 4health benefit plan who is provided a drug benefit by the 5health benefit plan.6    "Critical access pharmacy" means a critical access care 7pharmacy as defined in Section 5-5.12b of the Illinois Public 8Aid Code.9    "Drugs" has the meaning ascribed to that term in Section 3 10of the Pharmacy Practice Act and includes biological products.11    "Generic drug" means a drug that has been approved under 1242 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 13marketed, sold, or distributed directly or indirectly to the 14retail class of trade with labeling, packaging (other than 15repackaging as the listed drug in blister packs, unit doses, 16or similar packaging for use in institutions), product code, 17labeler code, trade name, or trademark that differs from that 18of the brand name drug.19    "Health benefit plan" means a policy, contract, 20certificate, or agreement entered into, offered, or issued by 21an insurer to provide, deliver, arrange for, pay for, or 22reimburse any of the costs of physical, mental, or behavioral 23health care services. Notwithstanding Sections 122-1 through 24122-4 of this Code, "health benefit plan" includes self-funded 25employee welfare benefit plans.26    "Maximum allowable cost" means the maximum amount that a   10400SB1390sam001- 7 -LRB104 08735 BAB 23976 a1pharmacy benefit manager will reimburse a pharmacy for the 2cost of a drug. 3    "Maximum allowable cost list" means a list of drugs for 4which a maximum allowable cost has been established by a 5pharmacy benefit manager. 6    "Pharmacy benefit manager" means a person, business, or 7entity, including a wholly or partially owned or controlled 8subsidiary of a pharmacy benefit manager, that provides claims 9processing services or other prescription drug or device 10services, or both, for health benefit plans.11    "Pharmacy services" means the provision of any services 12listed within the definition of "practice of pharmacy" under 13subsection (d) of Section 3 of the Pharmacy Practice Act.14    "Rare medical condition" means a physical, behavioral, or 15developmental condition that affects fewer than 200,000 16individuals in the United States or approximately 1 in 1,500 17individuals worldwide.18    "Rebate aggregator" means a person or entity, including 19group purchasing organizations, that negotiate rebates or 20other fees with drug manufacturers on behalf or for the 21benefit of a pharmacy benefit manager or its client and may 22also be involved in contracts that entitle the rebate 23aggregator or its client to receive rebates or other fees from 24drug manufacturers based on drug utilization or 25administration. 26    "Retail price" means the price an individual without   10400SB1390sam001- 8 -LRB104 08735 BAB 23976 a1prescription drug coverage would pay at a retail pharmacy, not 2including a pharmacist dispensing fee. 3    "Specialty drug" means a drug that:4        (1) is prescribed for a person with a complex or 5    chronic medical condition or a rare medical condition;6        (2) has limited or exclusive distribution; and7        (3) requires both:8            (A) specialized product handling by the dispensing 9        pharmacy or administration by the dispensing pharmacy; 10        and11            (B) specialized clinical care, including frequent 12        dosing adjustments, intensive clinical monitoring, or 13        expanded services for patients, including intensive 14        patient counseling, education, or ongoing clinical 15        support beyond traditional dispensing activities, such 16        as individualized disease and therapy management to 17        support improved health outcomes.18    "Spread pricing" means the model of drug pricing in which 19the pharmacy benefit manager charges a health benefit plan a 20contracted price for drugs, and the contracted price for the 21drugs differs from the amount the pharmacy benefit manager 22directly or indirectly pays the pharmacist or pharmacy for the 23drugs, pharmacist services, or drug and dispensing fees.24    "Steer" includes, but is not limited to:25        (1) requiring a covered individual to use only a 26    pharmacy, including a mail-order or specialty pharmacy, in   10400SB1390sam001- 9 -LRB104 08735 BAB 23976 a1    which the pharmacy benefit manager or its affiliate 2    maintains an ownership interest or control;3        (2) offering or implementing a plan design that 4    encourages a covered individual to use a pharmacy in which 5    the pharmacy benefit manager or an affiliate maintains an 6    ownership interest or control, if such plan design 7    increases costs for the covered individual. This includes 8    a plan design that requires a covered individual to pay 9    higher costs or an increased share of costs for a drug or 10    drug-related service if the covered individual uses a 11    pharmacy that is not owned or controlled by the pharmacy 12    benefit manager or its affiliate.13        (3) reimbursing a pharmacy or pharmacist for a drug 14    and pharmacist service in an amount less than the amount 15    that the pharmacy benefit manager reimburses itself or an 16    affiliate, including affiliated manufacturers or joint 17    ventures for providing the same drug or service. 18    "Third-party payer" means any entity that pays for 19prescription drugs on behalf of a patient other than a health 20care provider or sponsor of a plan subject to regulation under 21Medicare Part D, 42 U.S.C. 1395w-101 et seq.22    (a-5) In this Article, references to an "insurer" or 23"health insurer" shall include commercial private health 24insurance issuers, managed care organizations, managed care 25community networks, and any other third-party payer that 26contracts with pharmacy benefit managers or with the   10400SB1390sam001- 10 -LRB104 08735 BAB 23976 a1Department of Healthcare and Family Services to provide 2benefits or services under the Medicaid program or to 3otherwise engage in the administration or payment of pharmacy 4benefits. However, the terms do not refer to the plan sponsor 5of a self-funded, single-employer employee welfare benefit 6plan subject to 29 U.S.C. 1144.7    (b) A contract between a health insurer and a pharmacy 8benefit manager must require that the pharmacy benefit 9manager: 10        (1) Update maximum allowable cost pricing information 11    at least every 7 calendar days. 12        (2) Maintain a process that will, in a timely manner, 13    eliminate drugs from maximum allowable cost lists or 14    modify drug prices to remain consistent with changes in 15    pricing data used in formulating maximum allowable cost 16    prices and product availability. 17        (3) Provide access to its maximum allowable cost list 18    to each pharmacy or pharmacy services administrative 19    organization subject to the maximum allowable cost list. 20    Access may include a real-time pharmacy website portal to 21    be able to view the maximum allowable cost list. As used in 22    this Section, "pharmacy services administrative 23    organization" means an entity operating within the State 24    that contracts with independent pharmacies to conduct 25    business on their behalf with third-party payers. A 26    pharmacy services administrative organization may provide   10400SB1390sam001- 11 -LRB104 08735 BAB 23976 a1    administrative services to pharmacies and negotiate and 2    enter into contracts with third-party payers or pharmacy 3    benefit managers on behalf of pharmacies. 4        (4) Provide a process by which a contracted pharmacy 5    can appeal the provider's reimbursement for a drug subject 6    to maximum allowable cost pricing. The appeals process 7    must, at a minimum, include the following: 8            (A) A requirement that a contracted pharmacy has 9        14 calendar days after the applicable fill date to 10        appeal a maximum allowable cost if the reimbursement 11        for the drug is less than the net amount that the 12        network provider paid to the supplier of the drug. 13            (B) A requirement that a pharmacy benefit manager 14        must respond to a challenge within 14 calendar days of 15        the contracted pharmacy making the claim for which the 16        appeal has been submitted.17            (C) A telephone number and e-mail address or 18        website to network providers, at which the provider 19        can contact the pharmacy benefit manager to process 20        and submit an appeal.21            (D) A requirement that, if an appeal is denied, 22        the pharmacy benefit manager must provide the reason 23        for the denial and the name and the national drug code 24        number from national or regional wholesalers.25            (E) A requirement that, if an appeal is sustained, 26        the pharmacy benefit manager must make an adjustment   10400SB1390sam001- 12 -LRB104 08735 BAB 23976 a1        in the drug price effective the date the challenge is 2        resolved and make the adjustment applicable to all 3        similarly situated network pharmacy providers, as 4        determined by the managed care organization or 5        pharmacy benefit manager. 6        (5) Allow a plan sponsor or insurer whose coverage is 7    administered by the contracting with a pharmacy benefit 8    manager an annual right to audit compliance with the terms 9    of the contract by the pharmacy benefit manager, 10    including, but not limited to, full disclosure of any and 11    all rebate amounts secured, whether product specific or 12    generalized rebates, that were provided to the pharmacy 13    benefit manager by a pharmaceutical manufacturer. The cost 14    of the audit shall be borne exclusively by the pharmacy 15    benefit manager. 16        (6) Allow a plan sponsor or insurer whose coverage is 17    administered by the contracting with a pharmacy benefit 18    manager to request that the pharmacy benefit manager 19    disclose the actual amounts paid by the pharmacy benefit 20    manager to the pharmacy.21        (7) Provide notice to the plan sponsor or the insurer 22    party contracting with the pharmacy benefit manager of any 23    consideration that the pharmacy benefit manager receives 24    from the manufacturer for dispense as written 25    prescriptions once a generic or biologically similar 26    product becomes available.   10400SB1390sam001- 13 -LRB104 08735 BAB 23976 a1    (c) In order to place a particular prescription drug on a 2maximum allowable cost list, the pharmacy benefit manager 3must, at a minimum, ensure that: 4        (1) if the drug is a generically equivalent drug, it 5    is listed as therapeutically equivalent and 6    pharmaceutically equivalent "A" or "B" rated in the United 7    States Food and Drug Administration's most recent version 8    of the "Orange Book" or have an NR or NA rating by 9    Medi-Span, Gold Standard, or a similar rating by a 10    nationally recognized reference; 11        (2) the drug is available for purchase by each 12    pharmacy in the State from national or regional 13    wholesalers operating in Illinois; and 14        (3) the drug is not obsolete. 15    (d) A pharmacy benefit manager is prohibited from limiting 16a pharmacist's ability to disclose whether the cost-sharing 17obligation exceeds the retail price for a covered prescription 18drug, and the availability of a more affordable alternative 19drug, if one is available in accordance with Section 42 of the 20Pharmacy Practice Act. 21    (e) A health insurer or pharmacy benefit manager shall not 22require a covered individual an insured to make a payment for a 23prescription drug at the point of sale in an amount that 24exceeds the lesser of: 25        (1) the applicable cost-sharing amount; or26        (2) the retail price of the drug in the absence of   10400SB1390sam001- 14 -LRB104 08735 BAB 23976 a1    prescription drug coverage;2        (3) the discounted price available through a no cost 3    drug program or drug manufacturer voucher provided by or 4    for the covered individual at the point of sale; or5        (4) the discounted price available through a 6    discounted health care services plan provided by or for 7    the covered individual at the point of sale. 8    (f) Unless required by law, a contract between a pharmacy 9benefit manager or third-party payer and a 340B entity or 340B 10pharmacy shall not contain any provision that: 11        (1) distinguishes between drugs purchased through the 12    340B drug discount program and other drugs when 13    determining reimbursement or reimbursement methodologies, 14    or contains otherwise less favorable payment terms or 15    reimbursement methodologies for 340B entities or 340B 16    pharmacies when compared to similarly situated non-340B 17    entities; 18        (2) imposes any fee, chargeback, or rate adjustment 19    that is not similarly imposed on similarly situated 20    pharmacies that are not 340B entities or 340B pharmacies; 21        (3) imposes any fee, chargeback, or rate adjustment 22    that exceeds the fee, chargeback, or rate adjustment that 23    is not similarly imposed on similarly situated pharmacies 24    that are not 340B entities or 340B pharmacies; 25        (4) prevents or interferes with an individual's choice 26    to receive a covered prescription drug from a 340B entity   10400SB1390sam001- 15 -LRB104 08735 BAB 23976 a1    or 340B pharmacy through any legally permissible means, 2    except that nothing in this paragraph shall prohibit the 3    establishment of differing copayments or other 4    cost-sharing amounts within the health benefit plan for 5    covered individuals persons who acquire covered 6    prescription drugs from a nonpreferred or nonparticipating 7    provider; 8        (5) excludes a 340B entity or 340B pharmacy from a 9    pharmacy network on any basis that includes consideration 10    of whether the 340B entity or 340B pharmacy participates 11    in the 340B drug discount program; 12        (6) prevents a 340B entity or 340B pharmacy from using 13    a drug purchased under the 340B drug discount program; or 14        (7) any other provision that discriminates against a 15    340B entity or 340B pharmacy by treating the 340B entity 16    or 340B pharmacy differently than non-340B entities or 17    non-340B pharmacies for any reason relating to the 18    entity's participation in the 340B drug discount program. 19    As used in this subsection, "pharmacy benefit manager" and 20"third-party payer" do not include pharmacy benefit managers 21and third-party payers acting on behalf of a Medicaid program.22    (f-5) A pharmacy benefit manager or an affiliate acting on 23its behalf shall not conduct spread pricing.24    (f-10) A pharmacy benefit manager or an affiliate acting 25on its behalf shall not steer a covered individual.26    (f-15) A pharmacy benefit manager or rebate aggregator   10400SB1390sam001- 16 -LRB104 08735 BAB 23976 a1must remit no less than 90% of any amounts paid by a 2pharmaceutical manufacturer, wholesaler, or other distributor 3of a drug, including, but not limited to, rebates, group 4purchasing fees, and other fees, to the health benefit plan 5sponsor, covered individual, or employer. Records of rebates 6and fees remitted from the pharmacy benefit manager or rebate 7aggregator must be disclosed to the Department annually in a 8format to be specified by the Department.9    (f-20) A pharmacy benefit manager must not reimburse a 10critical access pharmacy for a drug or pharmacy service in an 11amount less than the national average drug acquisition cost 12for the drug or pharmacy service at the time the drug is 13administered or dispensed, plus the current Medicaid critical 14access pharmacy dispensing fee. If the national average drug 15acquisition cost is not available at the time a drug is 16administered or dispensed, a pharmacy benefit manager must not 17reimburse a critical access pharmacy for any drug at a rate 18that is less than the amount established by the Department of 19Healthcare and Family Services for the drug or service under 20the Medicaid program, as set forth in the applicable 21administrative rule, plus the current Medicaid critical access 22pharmacy dispensing fee.23    (f-25) A pharmacy benefit manager or an affiliate acting 24on its behalf is prohibited from limiting a covered 25individual's access to drugs from a pharmacy or pharmacist 26enrolled with the health benefit plan under the terms offered   10400SB1390sam001- 17 -LRB104 08735 BAB 23976 a1to all pharmacies in the plan coverage area, including by 2designating the covered drug as a specialty drug contrary to 3the definition in this Section.4    (f-30) The contract between the pharmacy benefit manager 5and the insurer or health benefit plan sponsor must allow and 6provide for the pharmacy benefit manager's compliance with an 7audit at least once per calendar year of the rebate and fee 8records remitted from a pharmacy benefit manager or its 9affiliated party to a health benefit plan. This audit may be 10incorporated into the audit under paragraph (5) of subsection 11(b) of this Section. Contracts with rebate aggregators, 12pharmacy services administrative organizations, pharmacies, or 13drug manufacturers must be available for audit by health 14benefit plan sponsors, insurers, or their designees at least 15once per plan year. Audits shall be performed by an auditor 16selected by the health benefit plan sponsor, insurer, or its 17designee. Health benefit plan sponsors and insurers shall give 18the pharmacy benefit manager a complete copy of the audit and 19the pharmacy benefit manager shall provide a complete copy of 20those findings to the Department within 60 days of initial 21receipt. Rebate contracts with rebate aggregators, pharmacy 22services administrative organizations, pharmacies, or drug 23manufacturers shall be available for audit by health benefit 24plan sponsor, insurer, or designee. Nothing in this Section 25shall limit the Department's ability to access the books and 26records and any and all copies thereof of pharmacy benefit   10400SB1390sam001- 18 -LRB104 08735 BAB 23976 a1managers, their affiliates, or affiliated rebate aggregators. 2    (g) A violation of this Section by a pharmacy benefit 3manager constitutes an unfair or deceptive act or practice in 4the business of insurance under Section 424. 5    (h) A provision that violates subsection (f) in a contract 6between a pharmacy benefit manager or a third-party payer and 7a 340B entity that is entered into, amended, or renewed after 8July 1, 2022 shall be void and unenforceable. This subsection 9and subsection (f) do not apply to a contract between a 340B 10entity and the plan sponsor of a self-funded, single-employer 11employee welfare benefit plan subject to 29 U.S.C. 1144. 12    (i)(1) A pharmacy benefit manager may not retaliate 13against a pharmacist or pharmacy for disclosing information in 14a court, in an administrative hearing, before a legislative 15commission or committee, or in any other proceeding, if the 16pharmacist or pharmacy has reasonable cause to believe that 17the disclosed information is evidence of a violation of a 18State or federal law, rule, or regulation.19    (2) A pharmacy benefit manager may not retaliate against a 20pharmacist or pharmacy for disclosing information to a 21government or law enforcement agency, if the pharmacist or 22pharmacy has reasonable cause to believe that the disclosed 23information is evidence of a violation of a State or federal 24law, rule, or regulation.25    (3) A pharmacist or pharmacy shall make commercially 26reasonable efforts to limit the disclosure of confidential and   10400SB1390sam001- 19 -LRB104 08735 BAB 23976 a1proprietary information.2    (4) Retaliatory actions against a pharmacy or pharmacist 3include cancellation of, restriction of, or refusal to renew 4or offer a contract to a pharmacy solely because the pharmacy 5or pharmacist has:6        (A) made disclosures of information that the 7    pharmacist or pharmacy has reasonable cause to believe is 8    evidence of a violation of a State or federal law, rule, or 9    regulation;10        (B) filed complaints with the plan or pharmacy benefit 11    manager; or12        (C) filed complaints against the plan or pharmacy 13    benefit manager with the Department.14    (j) This Section applies to contracts entered into or 15renewed on or after July 1, 2022 and, unless provided 16otherwise in this Section or in the Illinois Public Aid Code, 17applies to pharmacy benefit managers that are contracted with 18a Medicaid managed care entity on or after January 1, 2026. 19    (k) This Section applies to any health benefit group or 20individual policy of accident and health insurance or managed 21care plan that provides coverage for prescription drugs and 22that is amended, delivered, issued, or renewed on or after 23July 1, 2020. The changes made to this Section by this 24amendatory Act of the 104th General Assembly shall apply with 25respect to any health benefit plan that provides coverage for 26drugs that is amended, delivered, issued, or renewed on or   10400SB1390sam001- 20 -LRB104 08735 BAB 23976 a1after January 1, 2026. 2    (l) A pharmacy benefit manager is responsible for 3compliance with all State requirements applicable to pharmacy 4benefit managers even if an action or responsibility of a 5pharmacy benefit manager is delegated to or completed by a 6third party with an affiliation or a direct or indirect 7contractual relationship. 8(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; 9103-453, eff. 8-4-23.) 10    (215 ILCS 5/513b1.1 new)11    Sec. 513b1.1. Pharmacy benefit manager reporting 12requirements.13    (a) A pharmacy benefit manager that provides services for 14a health benefit plan must submit an annual report no later 15than September 1, to the Department, each health benefit plan 16sponsor, and each insurer that includes the following:17        (1) data on the health benefit plan including:18            (A) a list of drugs including corresponding 19        information on therapeutic class, brand name, generic 20        name, or specialty drug name;21            (B) number of covered individuals;22            (C) number of drug-related claims;23            (D) dosage units;24            (E) dispensing channel used;25            (F) wholesale acquisition cost per drug; and  10400SB1390sam001- 21 -LRB104 08735 BAB 23976 a1            (G) total out-of-pocket spending by deidentified 2        covered individual per drug, per transaction;3        (2) amount received by the health benefit plan in 4    rebates, fees, or discounts related to drug utilization or 5    spending;6        (3) total gross spending on drugs by the health 7    benefit plan;8        (4) total net spending, gross spending less 9    administrative portion of the medical loss ratio, spread 10    pricing, on drugs by the health benefit plan;11        (5) the amount paid by the health benefit plan to the 12    pharmacy benefit manager for reimbursement cost of a drug 13    and service per transaction;14        (6) the amount a pharmacy benefit manager paid for 15    pharmacists' services and drugs rendered related to the 16    health benefit plan per transaction, including, but not 17    limited to, any dispensing fee;18        (7) the specific rebate amount received by the 19    pharmacy benefit manager per transaction, the amount of 20    the rebates passed through to the health benefit plan per 21    transaction, and the amount of the rebates passed on to 22    covered individuals at the point of sale that reduced the 23    covered individuals' applicable deductible, copayment, 24    coinsurance, or other cost-sharing amount per transaction;25        (8) any information collected from drug manufacturers 26    pertaining to copayment assistance;  10400SB1390sam001- 22 -LRB104 08735 BAB 23976 a1        (9) any compensation paid to brokers, consultants, 2    advisors, or any other individual or firm for referrals, 3    consideration, or retention by the health benefit plan;4        (10) explanation of benefit design parameters 5    encouraging or requiring covered individuals to use 6    affiliated pharmacies, percentage of drugs charged by 7    these pharmacies, and a list of drugs dispensed by 8    affiliated pharmacies with their associated costs; and9        (11) a complete copy of each unredacted contract the 10    pharmacy benefit manager has with the health benefit plan 11    sponsor or insurer.12    (b) Annual reports pursuant to subsection (a):13        (1) must be written in plain language to ensure ease 14    of reading and accessibility.15        (2) must only contain summary health information to 16    ensure plan, coverage, or covered individual information 17    remains private and confidential.18        (3) upon request by a covered individual, must be 19    available in summary format and provide aggregated 20    information to help covered individuals understand their 21    health benefit plan's drug coverage.22        (4) must be filed with the Department no later than 23    September 1 of each year via the Systems for Electronic 24    Rates & Forms Filing (SERFF). The filing shall include the 25    summary version of the report described in paragraph (3) 26    of this subsection, which shall be marked for public   10400SB1390sam001- 23 -LRB104 08735 BAB 23976 a1    access.2    (c) A pharmacy benefit manager may petition the Department 3for a filing submission extension. The Director may grant or 4deny the extension within 5 business days.5    (d) Failure by a pharmacy benefit manager to submit all 6required elements in an annual report to the Department may 7result in a fine levied by the Director not to exceed $10,000 8per day, per offense. Funds derived from fines levied shall be 9deposited into the Insurance Producer Administration Fund. 10Fine information shall be posted on the Department's website.11    (e) A pharmacy benefit manager found in violation of 12subsection (a) or paragraph (4) of subsection (b) may request 13a hearing from the Director within 10 days of receipt of the 14Director's order, or, if the violation is found in a market 15conduct examination, as provided in Section 132 of this Code.16    (f) Except for the summary version, the annual reports 17submitted by pharmacy benefit managers shall be considered 18confidential and privileged for all purposes, including for 19purposes of the Freedom of Information Act, shall not be 20subject to subpoena from any private party, and shall not be 21admissible as evidence in a civil action.22    (g) A copy of an adverse decision against a pharmacy 23benefit manager for failing to submit an annual report to the 24Department must be posted to the Department's website.25    (h) Nothing in this Section shall be construed as 26permitting a pharmacy benefit manager to avoid or otherwise   10400SB1390sam001- 24 -LRB104 08735 BAB 23976 a1fail to comply with the reporting requirements set forth in 2Section 5-36 of the Illinois Public Aid Code. 3    (215 ILCS 5/513b3)4    Sec. 513b3. Examination. 5    (a) The Director, or his or her designee, may examine a 6registered pharmacy benefit manager related to all of its 7lines of business, including government programs, under the 8Director's jurisdiction in accordance with Sections 132-132.7. 9If the Director or the examiners find that the pharmacy 10benefit manager has violated this Article or any other 11insurance-related or health benefits-related laws, rules, or 12regulations under the Director's jurisdiction because of the 13manner in which the pharmacy benefit manager has conducted 14business on behalf of a health insurer or plan sponsor, then, 15unless the health insurer or plan sponsor is included in the 16examination and has been afforded the same opportunity to 17request or participate in a hearing on the examination report, 18the examination report shall not allege a violation by the 19health insurer or plan sponsor and the Director's order based 20on the report shall not impose any requirements, prohibitions, 21or penalties on the health insurer or plan sponsor. Nothing in 22this Section shall prevent the Director from using any 23information obtained during the examination of an 24administrator to examine, investigate, or take other 25appropriate regulatory or legal action with respect to a   10400SB1390sam001- 25 -LRB104 08735 BAB 23976 a1health insurer or plan sponsor.2    (b) The examination requirement for the pharmacy benefit 3manager to provide convenient and free access to all books and 4records under Sections 132 and 132.4 of this Code includes, at 5the Director's discretion, unredacted copies furnished 6electronically to the Director's market conduct surveillance 7personnel or examiners. Access must include information 8related to third-party entities affiliated or contracted with 9the pharmacy benefit manager, including, but not limited, to, 10rebate aggregators and pharmacy services administrative 11organizations. 12(Source: P.A. 103-897, eff. 1-1-25.) 13    Section 20. The Illinois Public Aid Code is amended by 14changing Sections 5-5.12b and 5-36 as follows: 15    (305 ILCS 5/5-5.12b)16    Sec. 5-5.12b. Critical access care pharmacy program.17    (a) As used in this Section: 18    "Critical access care pharmacy" means an Illinois-based 19brick and mortar pharmacy that is located in Illinois that is 20owned by a person or entity with an ownership or control 21interest in a county with fewer than 50,000 residents and that 22owns fewer than 10 pharmacies, and is either located in a 23county with fewer than 50,000 residents or in a county with 2450,000 or more residents and in an area within Illinois that is   10400SB1390sam001- 26 -LRB104 08735 BAB 23976 a1designated as a Medically Underserved Area by the Health 2Resources and Services Administration, an agency of the U.S. 3Department of Health and Human Services, or at the discretion 4of the Department of Healthcare and Family Services, as set 5forth in administrative rule. 6    "Critical access care pharmacy program payment" means the 7number of individual prescriptions a critical access care 8pharmacy fills during that quarter multiplied by the lesser of 9the individual payment amount or the dispensing reimbursement 10rate made by the Department under the medical assistance 11program as of April 1, 2018. 12    "Individual payment amount" means the dividend of 1/4 of 13the annual amount appropriated for the critical access care 14pharmacy program by the number of prescriptions filled by all 15critical access care pharmacies reimbursed by Medicaid managed 16care organizations that quarter. 17    (b) Subject to appropriations, the Department shall 18establish a critical access care pharmacy program to ensure 19the sustainability of critical access pharmacies throughout 20the State of Illinois. 21    (c) The critical access care pharmacy program shall not 22exceed $10,000,000 annually and individual payment amounts per 23prescription shall not exceed the dispensing rate that the 24Department would have reimbursed under the Medical Assistance 25Program as of April 1, 2018. 26    (d) Quarterly, the Department shall determine the number   10400SB1390sam001- 27 -LRB104 08735 BAB 23976 a1of prescriptions filled by critical access care pharmacies 2reimbursed by Medicaid managed care organizations utilizing 3encounter data available to the Department. The Department 4shall determine the individual payment amount per prescription 5by dividing 1/4 of the annual amount appropriated for the 6critical access care pharmacy program by the number of 7prescriptions filled by all critical access care pharmacies 8reimbursed by Medicaid managed care organizations that 9quarter. If the individual payment amount per prescription as 10calculated using quarterly prescription amounts exceeds the 11reimbursement rate under the medical assistance program as of 12April 1, 2018, then the individual payment amount per 13prescription shall be the dispensing reimbursement rate under 14the medical assistance program as of April 1, 2018. 15    (e) Quarterly, the Department shall distribute to critical 16access care pharmacies a critical access care pharmacy program 17payment. The first payment shall be calculated utilizing the 18encounter data from the last quarter of State fiscal year 192018.20    (f) The Department may adopt rules permitting an 21Illinois-based brick and mortar pharmacy that owns fewer than 2210 pharmacies to receive critical access care pharmacy program 23payments in the same manner as a critical access care 24pharmacy, regardless of whether the pharmacy is located in a 25county with a population of less than 50,000. 26(Source: P.A. 100-587, eff. 6-4-18.)   10400SB1390sam001- 28 -LRB104 08735 BAB 23976 a1    (305 ILCS 5/5-36)2    Sec. 5-36. Pharmacy benefits. 3    (a)(1) The Department may enter into a contract with a 4third party on a fee-for-service reimbursement model for the 5purpose of administering pharmacy benefits as provided in this 6Section for members not enrolled in a Medicaid managed care 7organization; however, these services shall be approved by the 8Department. The Department shall ensure coordination of care 9between the third-party administrator and managed care 10organizations as a consideration in any contracts established 11in accordance with this Section. Any managed care techniques, 12principles, or administration of benefits utilized in 13accordance with this subsection shall comply with State law. 14    (2) The following shall apply to contracts between 15entities contracting relating to the Department's third-party 16administrators and pharmacies: 17        (A) the Department shall approve any contract between 18    a third-party administrator and a pharmacy;19        (B) the Department's third-party administrator shall 20    not change the terms of a contract between a third-party 21    administrator and a pharmacy without written approval by 22    the Department; and23        (C) the Department's third-party administrator shall 24    not create, modify, implement, or indirectly establish any 25    fee on a pharmacy, pharmacist, or a recipient of medical   10400SB1390sam001- 29 -LRB104 08735 BAB 23976 a1    assistance without written approval by the Department. 2    (b) The provisions of this Section shall not apply to 3outpatient pharmacy services provided by a health care 4facility registered as a covered entity pursuant to 42 U.S.C. 5256b or any pharmacy owned by or contracted with the covered 6entity. A Medicaid managed care organization shall, either 7directly or through a pharmacy benefit manager, administer and 8reimburse outpatient pharmacy claims submitted by a health 9care facility registered as a covered entity pursuant to 42 10U.S.C. 256b, its owned pharmacies, and contracted pharmacies 11in accordance with the contractual agreements the Medicaid 12managed care organization or its pharmacy benefit manager has 13with such facilities and pharmacies and in accordance with 14subsection (h-5). 15    (b-5) Any pharmacy benefit manager that contracts with a 16Medicaid managed care organization to administer and reimburse 17pharmacy claims as provided in this Section must be registered 18with the Director of Insurance in accordance with Section 19513b2 of the Illinois Insurance Code. A pharmacy benefit 20manager must comply with all provisions of Article XXXIIB of 21the Illinois Insurance Code to the extent that they do not 22prevent the application of any provision of this Article or 23applicable federal law. Nothing in this Section shall be 24construed to limit the authority of the Illinois Department or 25the Inspector General to administer or enforce any provisions 26of this Section or any other Section in the Illinois Public Aid   10400SB1390sam001- 30 -LRB104 08735 BAB 23976 a1Code related to pharmacy benefit managers or Medicaid managed 2care entity. 3    (c) On at least an annual basis, the Director of the 4Department of Healthcare and Family Services shall submit a 5report beginning no later than one year after January 1, 2020 6(the effective date of Public Act 101-452) that provides an 7update on any contract, contract issues, formulary, dispensing 8fees, and maximum allowable cost concerns regarding a 9third-party administrator and managed care. The requirement 10for reporting to the General Assembly shall be satisfied by 11filing copies of the report with the Speaker, the Minority 12Leader, and the Clerk of the House of Representatives and with 13the President, the Minority Leader, and the Secretary of the 14Senate. The Department shall take care that no proprietary 15information is included in the report required under this 16Section. 17    (d) (Blank). A pharmacy benefit manager shall notify the 18Department in writing of any activity, policy, or practice of 19the pharmacy benefit manager that directly or indirectly 20presents a conflict of interest that interferes with the 21discharge of the pharmacy benefit manager's duty to a managed 22care organization to exercise its contractual duties. 23"Conflict of interest" shall be defined by rule by the 24Department.25    (e) A pharmacy benefit manager shall, upon request, 26disclose to the Department the following information:   10400SB1390sam001- 31 -LRB104 08735 BAB 23976 a1        (1) whether the pharmacy benefit manager has a 2    contract, agreement, or other arrangement with a 3    pharmaceutical manufacturer to exclusively dispense or 4    provide a drug to a managed care organization's enrollees, 5    and the aggregate amounts of consideration of economic 6    benefits collected or received pursuant to that 7    arrangement; 8        (2) the percentage of claims payments made by the 9    pharmacy benefit manager to pharmacies owned, managed, or 10    controlled by the pharmacy benefit manager or any of the 11    pharmacy benefit manager's management companies, parent 12    companies, subsidiary companies, or jointly held 13    companies; 14        (3) the aggregate amount of the fees or assessments 15    imposed on, or collected from, pharmacy providers; 16        (4) the average annualized percentage of revenue 17    collected by the pharmacy benefit manager as a result of 18    each contract it has executed with a managed care 19    organization contracted by the Department to provide 20    medical assistance benefits which is not paid by the 21    pharmacy benefit manager to pharmacy providers and 22    pharmaceutical manufacturers or labelers or in order to 23    perform administrative functions pursuant to its contracts 24    with managed care organizations; 25        (5) the total number of prescriptions dispensed under 26    each contract the pharmacy benefit manager has with a   10400SB1390sam001- 32 -LRB104 08735 BAB 23976 a1    managed care organization (MCO) contracted by the 2    Department to provide medical assistance benefits;3        (6) the aggregate wholesale acquisition cost for drugs 4    that were dispensed to enrollees in each MCO with which 5    the pharmacy benefit manager has a contract by any 6    pharmacy owned, managed, or controlled by the pharmacy 7    benefit manager or any of the pharmacy benefit manager's 8    management companies, parent companies, subsidiary 9    companies, or jointly-held companies; 10        (7) the aggregate amount of administrative fees that 11    the pharmacy benefit manager received from all 12    pharmaceutical manufacturers for prescriptions dispensed 13    to MCO enrollees; 14        (8) for each MCO with which the pharmacy benefit 15    manager has a contract, the aggregate amount of payments 16    received by the pharmacy benefit manager from the MCO; 17        (9) for each MCO with which the pharmacy benefit 18    manager has a contract, the aggregate amount of 19    reimbursements the pharmacy benefit manager paid to 20    contracting pharmacies; and 21        (10) any other information considered necessary by the 22    Department. 23    (f) The information disclosed under subsection (e) shall 24include all retail, mail order, specialty, and compounded 25prescription products. All information made available to the 26Department under subsection (e) is confidential and not   10400SB1390sam001- 33 -LRB104 08735 BAB 23976 a1subject to disclosure under the Freedom of Information Act. 2All information made available to the Department under 3subsection (e) shall not be reported or distributed in any way 4that compromises its competitive, proprietary, or financial 5value. The information shall only be used by the Department to 6assess the contract, agreement, or other arrangements made 7between a pharmacy benefit manager and a pharmacy provider, 8pharmaceutical manufacturer or labeler, managed care 9organization, or other entity, as applicable. 10    (g) A pharmacy benefit manager shall disclose directly in 11writing to a pharmacy provider or pharmacy services 12administrative organization contracting with the pharmacy 13benefit manager of any material change to a contract provision 14that affects the terms of the reimbursement, the process for 15verifying benefits and eligibility, dispute resolution, 16procedures for verifying drugs included on the formulary, and 17contract termination at least 30 days prior to the date of the 18change to the provision. The terms of this subsection shall be 19deemed met if the pharmacy benefit manager posts the 20information on a website, viewable by the public. A pharmacy 21service administration organization shall notify all contract 22pharmacies of any material change, as described in this 23subsection, within 2 days of notification. As used in this 24Section, "pharmacy services administrative organization" means 25an entity operating within the State that contracts with 26independent pharmacies to conduct business on their behalf   10400SB1390sam001- 34 -LRB104 08735 BAB 23976 a1with third-party payers. A pharmacy services administrative 2organization may provide administrative services to pharmacies 3and negotiate and enter into contracts with third-party payers 4or pharmacy benefit managers on behalf of pharmacies. 5    (h) A pharmacy benefit manager shall not include the 6following in a contract with a pharmacy provider: 7        (1) a provision prohibiting the provider from 8    informing a patient of a less costly alternative to a 9    prescribed medication; or 10        (2) a provision that prohibits the provider from 11    dispensing a particular amount of a prescribed medication, 12    if the pharmacy benefit manager allows that amount to be 13    dispensed through a pharmacy owned or controlled by the 14    pharmacy benefit manager, unless the prescription drug is 15    subject to restricted distribution by the United States 16    Food and Drug Administration or requires special handling, 17    provider coordination, or patient education that cannot be 18    provided by a retail pharmacy. 19    (h-5) Unless required by law, a Medicaid managed care 20organization or pharmacy benefit manager administering or 21managing benefits on behalf of a Medicaid managed care 22organization shall not refuse to contract with a 340B entity 23or 340B pharmacy for refusing to accept less favorable payment 24terms or reimbursement methodologies when compared to 25similarly situated non-340B entities and shall not include in 26a contract with a 340B entity or 340B pharmacy a provision   10400SB1390sam001- 35 -LRB104 08735 BAB 23976 a1that: 2        (1) imposes any fee, chargeback, or rate adjustment 3    that is not similarly imposed on similarly situated 4    pharmacies that are not 340B entities or 340B pharmacies; 5        (2) imposes any fee, chargeback, or rate adjustment 6    that exceeds the fee, chargeback, or rate adjustment that 7    is not similarly imposed on similarly situated pharmacies 8    that are not 340B entities or 340B pharmacies; 9        (3) prevents or interferes with an individual's choice 10    to receive a prescription drug from a 340B entity or 340B 11    pharmacy through any legally permissible means; 12        (4) excludes a 340B entity or 340B pharmacy from a 13    pharmacy network on the basis of whether the 340B entity 14    or 340B pharmacy participates in the 340B drug discount 15    program; 16        (5) prevents a 340B entity or 340B pharmacy from using 17    a drug purchased under the 340B drug discount program so 18    long as the drug recipient is a patient of the 340B entity; 19    nothing in this Section exempts a 340B pharmacy from 20    following the Department's preferred drug list or from any 21    prior approval requirements of the Department or the 22    Medicaid managed care organization that are imposed on the 23    drug for all pharmacies; or 24        (6) any other provision that discriminates against a 25    340B entity or 340B pharmacy by treating a 340B entity or 26    340B pharmacy differently than non-340B entities or   10400SB1390sam001- 36 -LRB104 08735 BAB 23976 a1    non-340B pharmacies for any reason relating to the 2    entity's participation in the 340B drug discount program. 3    A provision that violates this subsection in any contract 4between a Medicaid managed care organization or its pharmacy 5benefit manager and a 340B entity entered into, amended, or 6renewed after July 1, 2022 shall be void and unenforceable. 7    In this subsection (h-5):8    "340B entity" means a covered entity as defined in 42 9U.S.C. 256b(a)(4) authorized to participate in the 340B drug 10discount program.11    "340B pharmacy" means any pharmacy used to dispense 340B 12drugs for a covered entity, whether entity-owned or external. 13    (i) Nothing in this Section shall be construed to prohibit 14a pharmacy benefit manager from requiring the same 15reimbursement and terms and conditions for a pharmacy provider 16as for a pharmacy owned, controlled, or otherwise associated 17with the pharmacy benefit manager. 18    (j) A pharmacy benefit manager shall establish and 19implement a process for the resolution of disputes arising out 20of this Section, which shall be approved by the Department. 21    (k) The Department shall adopt rules establishing 22reasonable dispensing fees for fee-for-service payments in 23accordance with guidance or guidelines from the federal 24Centers for Medicare and Medicaid Services.25(Source: P.A. 102-558, eff. 8-20-21; 102-778, eff. 7-1-22; 26103-593, eff. 6-7-24.)   10400SB1390sam001- 37 -LRB104 08735 BAB 23976 a1    Section 25. The Juvenile Court Act of 1987 is amended by 2changing Section 5-515 as follows: 3    (705 ILCS 405/5-515)4    Sec. 5-515. Medical, and dental, and pharmaceutical 5treatment and care. 6    (a) At all times during temporary custody, detention or 7shelter care, the court may authorize a physician, a hospital 8or any other appropriate health care provider to provide 9medical, dental or surgical procedures or pharmaceuticals if 10those procedures or pharmaceuticals are necessary to safeguard 11the minor's life or health. If the minor is covered under an 12existing medical or dental plan, the county shall be 13reimbursed for the expenses incurred for such services as if 14the minor were not held in temporary custody, detention, or 15shelter care.16    (b) If a provider of temporary custody, detention, or 17shelter care has a contract with a pharmacy benefit manager or 18a contract with an insurance company, health maintenance 19organization, limited health service organization, 20administrative services organization, or any other managed 21care organization or health insurance issuer where a pharmacy 22benefit manager administers the provider's coverage of, 23payment for, or formulary design for drugs necessary to 24safeguard the minor's life or health, the contract with the   10400SB1390sam001- 38 -LRB104 08735 BAB 23976 a1pharmacy benefit manager and the pharmacy benefit manager's 2activities shall be subject to Article XXXIIB of the Illinois 3Insurance Code and the authority of the Director of Insurance 4to enforce such provisions. The provider shall have all the 5rights of a plan sponsor under those provisions. 6(Source: P.A. 90-590, eff. 1-1-99.) 7    Section 30. The Unified Code of Corrections is amended by 8changing Section 3-2-2 as follows: 9    (730 ILCS 5/3-2-2)  (from Ch. 38, par. 1003-2-2)10    Sec. 3-2-2. Powers and duties of the Department. 11    (1) In addition to the powers, duties, and 12responsibilities which are otherwise provided by law, the 13Department shall have the following powers:14        (a) To accept persons committed to it by the courts of 15    this State for care, custody, treatment, and 16    rehabilitation, and to accept federal prisoners and 17    noncitizens over whom the Office of the Federal Detention 18    Trustee is authorized to exercise the federal detention 19    function for limited purposes and periods of time.20        (b) To develop and maintain reception and evaluation 21    units for purposes of analyzing the custody and 22    rehabilitation needs of persons committed to it and to 23    assign such persons to institutions and programs under its 24    control or transfer them to other appropriate agencies. In   10400SB1390sam001- 39 -LRB104 08735 BAB 23976 a1    consultation with the Department of Alcoholism and 2    Substance Abuse (now the Department of Human Services), 3    the Department of Corrections shall develop a master plan 4    for the screening and evaluation of persons committed to 5    its custody who have alcohol or drug abuse problems, and 6    for making appropriate treatment available to such 7    persons; the Department shall report to the General 8    Assembly on such plan not later than April 1, 1987. The 9    maintenance and implementation of such plan shall be 10    contingent upon the availability of funds.11        (b-1) To create and implement, on January 1, 2002, a 12    pilot program to establish the effectiveness of 13    pupillometer technology (the measurement of the pupil's 14    reaction to light) as an alternative to a urine test for 15    purposes of screening and evaluating persons committed to 16    its custody who have alcohol or drug problems. The pilot 17    program shall require the pupillometer technology to be 18    used in at least one Department of Corrections facility. 19    The Director may expand the pilot program to include an 20    additional facility or facilities as he or she deems 21    appropriate. A minimum of 4,000 tests shall be included in 22    the pilot program. The Department must report to the 23    General Assembly on the effectiveness of the program by 24    January 1, 2003.25        (b-5) To develop, in consultation with the Illinois 26    State Police, a program for tracking and evaluating each   10400SB1390sam001- 40 -LRB104 08735 BAB 23976 a1    inmate from commitment through release for recording his 2    or her gang affiliations, activities, or ranks.3        (c) To maintain and administer all State correctional 4    institutions and facilities under its control and to 5    establish new ones as needed. Pursuant to its power to 6    establish new institutions and facilities, the Department 7    may, with the written approval of the Governor, authorize 8    the Department of Central Management Services to enter 9    into an agreement of the type described in subsection (d) 10    of Section 405-300 of the Department of Central Management 11    Services Law. The Department shall designate those 12    institutions which shall constitute the State Penitentiary 13    System. The Department of Juvenile Justice shall maintain 14    and administer all State youth centers pursuant to 15    subsection (d) of Section 3-2.5-20. 16        Pursuant to its power to establish new institutions 17    and facilities, the Department may authorize the 18    Department of Central Management Services to accept bids 19    from counties and municipalities for the construction, 20    remodeling, or conversion of a structure to be leased to 21    the Department of Corrections for the purposes of its 22    serving as a correctional institution or facility. Such 23    construction, remodeling, or conversion may be financed 24    with revenue bonds issued pursuant to the Industrial 25    Building Revenue Bond Act by the municipality or county. 26    The lease specified in a bid shall be for a term of not   10400SB1390sam001- 41 -LRB104 08735 BAB 23976 a1    less than the time needed to retire any revenue bonds used 2    to finance the project, but not to exceed 40 years. The 3    lease may grant to the State the option to purchase the 4    structure outright.5        Upon receipt of the bids, the Department may certify 6    one or more of the bids and shall submit any such bids to 7    the General Assembly for approval. Upon approval of a bid 8    by a constitutional majority of both houses of the General 9    Assembly, pursuant to joint resolution, the Department of 10    Central Management Services may enter into an agreement 11    with the county or municipality pursuant to such bid.12        (c-5) To build and maintain regional juvenile 13    detention centers and to charge a per diem to the counties 14    as established by the Department to defray the costs of 15    housing each minor in a center. In this subsection (c-5), 16    "juvenile detention center" means a facility to house 17    minors during pendency of trial who have been transferred 18    from proceedings under the Juvenile Court Act of 1987 to 19    prosecutions under the criminal laws of this State in 20    accordance with Section 5-805 of the Juvenile Court Act of 21    1987, whether the transfer was by operation of law or 22    permissive under that Section. The Department shall 23    designate the counties to be served by each regional 24    juvenile detention center.25        (d) To develop and maintain programs of control, 26    rehabilitation, and employment of committed persons within   10400SB1390sam001- 42 -LRB104 08735 BAB 23976 a1    its institutions.2        (d-5) To provide a pre-release job preparation program 3    for inmates at Illinois adult correctional centers. 4        (d-10) To provide educational and visitation 5    opportunities to committed persons within its institutions 6    through temporary access to content-controlled tablets 7    that may be provided as a privilege to committed persons 8    to induce or reward compliance. 9        (e) To establish a system of supervision and guidance 10    of committed persons in the community.11        (f) To establish in cooperation with the Department of 12    Transportation to supply a sufficient number of prisoners 13    for use by the Department of Transportation to clean up 14    the trash and garbage along State, county, township, or 15    municipal highways as designated by the Department of 16    Transportation. The Department of Corrections, at the 17    request of the Department of Transportation, shall furnish 18    such prisoners at least annually for a period to be agreed 19    upon between the Director of Corrections and the Secretary 20    of Transportation. The prisoners used on this program 21    shall be selected by the Director of Corrections on 22    whatever basis he deems proper in consideration of their 23    term, behavior and earned eligibility to participate in 24    such program - where they will be outside of the prison 25    facility but still in the custody of the Department of 26    Corrections. Prisoners convicted of first degree murder,   10400SB1390sam001- 43 -LRB104 08735 BAB 23976 a1    or a Class X felony, or armed violence, or aggravated 2    kidnapping, or criminal sexual assault, aggravated 3    criminal sexual abuse or a subsequent conviction for 4    criminal sexual abuse, or forcible detention, or arson, or 5    a prisoner adjudged a Habitual Criminal shall not be 6    eligible for selection to participate in such program. The 7    prisoners shall remain as prisoners in the custody of the 8    Department of Corrections and such Department shall 9    furnish whatever security is necessary. The Department of 10    Transportation shall furnish trucks and equipment for the 11    highway cleanup program and personnel to supervise and 12    direct the program. Neither the Department of Corrections 13    nor the Department of Transportation shall replace any 14    regular employee with a prisoner.15        (g) To maintain records of persons committed to it and 16    to establish programs of research, statistics, and 17    planning.18        (h) To investigate the grievances of any person 19    committed to the Department and to inquire into any 20    alleged misconduct by employees or committed persons; and 21    for these purposes it may issue subpoenas and compel the 22    attendance of witnesses and the production of writings and 23    papers, and may examine under oath any witnesses who may 24    appear before it; to also investigate alleged violations 25    of a parolee's or releasee's conditions of parole or 26    release; and for this purpose it may issue subpoenas and   10400SB1390sam001- 44 -LRB104 08735 BAB 23976 a1    compel the attendance of witnesses and the production of 2    documents only if there is reason to believe that such 3    procedures would provide evidence that such violations 4    have occurred.5        If any person fails to obey a subpoena issued under 6    this subsection, the Director may apply to any circuit 7    court to secure compliance with the subpoena. The failure 8    to comply with the order of the court issued in response 9    thereto shall be punishable as contempt of court.10        (i) To appoint and remove the chief administrative 11    officers, and administer programs of training and 12    development of personnel of the Department. Personnel 13    assigned by the Department to be responsible for the 14    custody and control of committed persons or to investigate 15    the alleged misconduct of committed persons or employees 16    or alleged violations of a parolee's or releasee's 17    conditions of parole shall be conservators of the peace 18    for those purposes, and shall have the full power of peace 19    officers outside of the facilities of the Department in 20    the protection, arrest, retaking, and reconfining of 21    committed persons or where the exercise of such power is 22    necessary to the investigation of such misconduct or 23    violations. This subsection shall not apply to persons 24    committed to the Department of Juvenile Justice under the 25    Juvenile Court Act of 1987 on aftercare release.26        (j) To cooperate with other departments and agencies   10400SB1390sam001- 45 -LRB104 08735 BAB 23976 a1    and with local communities for the development of 2    standards and programs for better correctional services in 3    this State.4        (k) To administer all moneys and properties of the 5    Department.6        (l) To report annually to the Governor on the 7    committed persons, institutions, and programs of the 8    Department.9        (l-5) (Blank).10        (m) To make all rules and regulations and exercise all 11    powers and duties vested by law in the Department.12        (n) To establish rules and regulations for 13    administering a system of sentence credits, established in 14    accordance with Section 3-6-3, subject to review by the 15    Prisoner Review Board.16        (o) To administer the distribution of funds from the 17    State Treasury to reimburse counties where State penal 18    institutions are located for the payment of assistant 19    state's attorneys' salaries under Section 4-2001 of the 20    Counties Code.21        (p) To exchange information with the Department of 22    Human Services and the Department of Healthcare and Family 23    Services for the purpose of verifying living arrangements 24    and for other purposes directly connected with the 25    administration of this Code and the Illinois Public Aid 26    Code.  10400SB1390sam001- 46 -LRB104 08735 BAB 23976 a1        (q) To establish a diversion program.2        The program shall provide a structured environment for 3    selected technical parole or mandatory supervised release 4    violators and committed persons who have violated the 5    rules governing their conduct while in work release. This 6    program shall not apply to those persons who have 7    committed a new offense while serving on parole or 8    mandatory supervised release or while committed to work 9    release.10        Elements of the program shall include, but shall not 11    be limited to, the following:12            (1) The staff of a diversion facility shall 13        provide supervision in accordance with required 14        objectives set by the facility.15            (2) Participants shall be required to maintain 16        employment.17            (3) Each participant shall pay for room and board 18        at the facility on a sliding-scale basis according to 19        the participant's income.20            (4) Each participant shall:21                (A) provide restitution to victims in 22            accordance with any court order;23                (B) provide financial support to his 24            dependents; and25                (C) make appropriate payments toward any other 26            court-ordered obligations.  10400SB1390sam001- 47 -LRB104 08735 BAB 23976 a1            (5) Each participant shall complete community 2        service in addition to employment.3            (6) Participants shall take part in such 4        counseling, educational, and other programs as the 5        Department may deem appropriate.6            (7) Participants shall submit to drug and alcohol 7        screening.8            (8) The Department shall promulgate rules 9        governing the administration of the program.10        (r) To enter into intergovernmental cooperation 11    agreements under which persons in the custody of the 12    Department may participate in a county impact 13    incarceration program established under Section 3-6038 or 14    3-15003.5 of the Counties Code.15        (r-5) (Blank).16        (r-10) To systematically and routinely identify with 17    respect to each streetgang active within the correctional 18    system: (1) each active gang; (2) every existing 19    inter-gang affiliation or alliance; and (3) the current 20    leaders in each gang. The Department shall promptly 21    segregate leaders from inmates who belong to their gangs 22    and allied gangs. "Segregate" means no physical contact 23    and, to the extent possible under the conditions and space 24    available at the correctional facility, prohibition of 25    visual and sound communication. For the purposes of this 26    paragraph (r-10), "leaders" means persons who:  10400SB1390sam001- 48 -LRB104 08735 BAB 23976 a1            (i) are members of a criminal streetgang;2            (ii) with respect to other individuals within the 3        streetgang, occupy a position of organizer, 4        supervisor, or other position of management or 5        leadership; and6            (iii) are actively and personally engaged in 7        directing, ordering, authorizing, or requesting 8        commission of criminal acts by others, which are 9        punishable as a felony, in furtherance of streetgang 10        related activity both within and outside of the 11        Department of Corrections.12    "Streetgang", "gang", and "streetgang related" have the 13    meanings ascribed to them in Section 10 of the Illinois 14    Streetgang Terrorism Omnibus Prevention Act.15        (s) To operate a super-maximum security institution, 16    in order to manage and supervise inmates who are 17    disruptive or dangerous and provide for the safety and 18    security of the staff and the other inmates.19        (t) To monitor any unprivileged conversation or any 20    unprivileged communication, whether in person or by mail, 21    telephone, or other means, between an inmate who, before 22    commitment to the Department, was a member of an organized 23    gang and any other person without the need to show cause or 24    satisfy any other requirement of law before beginning the 25    monitoring, except as constitutionally required. The 26    monitoring may be by video, voice, or other method of   10400SB1390sam001- 49 -LRB104 08735 BAB 23976 a1    recording or by any other means. As used in this 2    subdivision (1)(t), "organized gang" has the meaning 3    ascribed to it in Section 10 of the Illinois Streetgang 4    Terrorism Omnibus Prevention Act.5        As used in this subdivision (1)(t), "unprivileged 6    conversation" or "unprivileged communication" means a 7    conversation or communication that is not protected by any 8    privilege recognized by law or by decision, rule, or order 9    of the Illinois Supreme Court.10        (u) To establish a Women's and Children's Pre-release 11    Community Supervision Program for the purpose of providing 12    housing and services to eligible female inmates, as 13    determined by the Department, and their newborn and young 14    children.15        (u-5) To issue an order, whenever a person committed 16    to the Department absconds or absents himself or herself, 17    without authority to do so, from any facility or program 18    to which he or she is assigned. The order shall be 19    certified by the Director, the Supervisor of the 20    Apprehension Unit, or any person duly designated by the 21    Director, with the seal of the Department affixed. The 22    order shall be directed to all sheriffs, coroners, and 23    police officers, or to any particular person named in the 24    order. Any order issued pursuant to this subdivision 25    (1)(u-5) shall be sufficient warrant for the officer or 26    person named in the order to arrest and deliver the   10400SB1390sam001- 50 -LRB104 08735 BAB 23976 a1    committed person to the proper correctional officials and 2    shall be executed the same as criminal process. 3        (u-6) To appoint a point of contact person who shall 4    receive suggestions, complaints, or other requests to the 5    Department from visitors to Department institutions or 6    facilities and from other members of the public.7        (v) To do all other acts necessary to carry out the 8    provisions of this Chapter.9    (2) The Department of Corrections shall by January 1, 101998, consider building and operating a correctional facility 11within 100 miles of a county of over 2,000,000 inhabitants, 12especially a facility designed to house juvenile participants 13in the impact incarceration program.14    (3) When the Department lets bids for contracts for 15medical services to be provided to persons committed to 16Department facilities by a health maintenance organization, 17medical service corporation, or other health care provider, 18the bid may only be let to a health care provider that has 19obtained an irrevocable letter of credit or performance bond 20issued by a company whose bonds have an investment grade or 21higher rating by a bond rating organization.22    (3.5) If the Department has a contract with a pharmacy 23benefit manager or a contract with an insurance company, 24health maintenance organization, limited health service 25organization, administrative services organization, or any 26other managed care entity or health insurance issuer where a   10400SB1390sam001- 51 -LRB104 08735 BAB 23976 a1pharmacy benefit manager administers the provider's coverage 2of, payment for, or formulary design for drugs necessary to 3safeguard the minor's life or health, the contract with the 4pharmacy benefit manager and the pharmacy benefit manager's 5activities shall be subject to Article XXXIIB of the Illinois 6Insurance Code and the authority of the Director of Insurance 7to enforce such provisions. The provider shall have all the 8rights of a plan sponsor under those provisions. 9    (4) When the Department lets bids for contracts for food 10or commissary services to be provided to Department 11facilities, the bid may only be let to a food or commissary 12services provider that has obtained an irrevocable letter of 13credit or performance bond issued by a company whose bonds 14have an investment grade or higher rating by a bond rating 15organization.16    (5) On and after the date 6 months after August 16, 2013 17(the effective date of Public Act 98-488), as provided in the 18Executive Order 1 (2012) Implementation Act, all of the 19powers, duties, rights, and responsibilities related to State 20healthcare purchasing under this Code that were transferred 21from the Department of Corrections to the Department of 22Healthcare and Family Services by Executive Order 3 (2005) are 23transferred back to the Department of Corrections; however, 24powers, duties, rights, and responsibilities related to State 25healthcare purchasing under this Code that were exercised by 26the Department of Corrections before the effective date of   10400SB1390sam001- 52 -LRB104 08735 BAB 23976 a1Executive Order 3 (2005) but that pertain to individuals 2resident in facilities operated by the Department of Juvenile 3Justice are transferred to the Department of Juvenile Justice. 4    (6) The Department of Corrections shall provide lactation 5or nursing mothers rooms for personnel of the Department. The 6rooms shall be provided in each facility of the Department 7that employs nursing mothers. Each individual lactation room 8must: 9        (i) contain doors that lock; 10        (ii) have an "Occupied" sign for each door; 11        (iii) contain electrical outlets for plugging in 12    breast pumps; 13        (iv) have sufficient lighting and ventilation; 14        (v) contain comfortable chairs; 15        (vi) contain a countertop or table for all necessary 16    supplies for lactation; 17        (vii) contain a wastebasket and chemical cleaners to 18    wash one's hands and to clean the surfaces of the 19    countertop or table; 20        (viii) have a functional sink; 21        (ix) have a minimum of one refrigerator for storage of 22    the breast milk; and 23        (x) receive routine daily maintenance. 24(Source: P.A. 102-350, eff. 8-13-21; 102-535, eff. 1-1-22; 25102-538, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1030, eff. 265-27-22; 103-834, eff. 1-1-25.)   10400SB1390sam001- 53 -LRB104 08735 BAB 23976 a1    Section 35. The County Jail Act is amended by changing 2Section 17 as follows: 3    (730 ILCS 125/17)  (from Ch. 75, par. 117)4    Sec. 17. Bedding, clothing, fuel, and medical aid; 5reimbursement for medical expenses. The Warden of the jail 6shall furnish necessary bedding, clothing, fuel, and medical 7services for all committed persons under his charge, and keep 8an accurate account of the same. When services that result in 9qualified medical expenses are required by any person held in 10custody, the county, private hospital, physician or any public 11agency which provides such services shall be entitled to 12obtain reimbursement from the county for the cost of such 13services. The county board of a county may adopt an ordinance 14or resolution providing for reimbursement for the cost of 15those services at the Department of Healthcare and Family 16Services' rates for medical assistance. To the extent that 17such person is reasonably able to pay for such care, including 18reimbursement from any insurance program or from other medical 19benefit programs available to such person, he or she shall 20reimburse the county or arresting authority. If such person 21has already been determined eligible for medical assistance 22under the Illinois Public Aid Code at the time the person is 23detained, the cost of such services, to the extent such cost 24exceeds $500, shall be reimbursed by the Department of   10400SB1390sam001- 54 -LRB104 08735 BAB 23976 a1Healthcare and Family Services under that Code. A 2reimbursement under any public or private program authorized 3by this Section shall be paid to the county or arresting 4authority to the same extent as would have been obtained had 5the services been rendered in a non-custodial environment.6    The sheriff or his or her designee may cause an 7application for medical assistance under the Illinois Public 8Aid Code to be completed for an arrestee who is a hospital 9inpatient. If such arrestee is determined eligible, he or she 10shall receive medical assistance under the Code for hospital 11inpatient services only. An arresting authority shall be 12responsible for any qualified medical expenses relating to the 13arrestee until such time as the arrestee is placed in the 14custody of the sheriff. However, the arresting authority shall 15not be so responsible if the arrest was made pursuant to a 16request by the sheriff. When medical expenses are required by 17any person held in custody, the county shall be entitled to 18obtain reimbursement from the County Jail Medical Costs Fund 19to the extent moneys are available from the Fund. To the extent 20that the person is reasonably able to pay for that care, 21including reimbursement from any insurance program or from 22other medical benefit programs available to the person, he or 23she shall reimburse the county.24    For the purposes of this Section, "arresting authority" 25means a unit of local government, other than a county, which 26employs peace officers and whose peace officers have made the   10400SB1390sam001- 55 -LRB104 08735 BAB 23976 a1arrest of a person. For the purposes of this Section, 2"qualified medical expenses" include medical and hospital 3services but do not include (i) expenses incurred for medical 4care or treatment provided to a person on account of a 5self-inflicted injury incurred prior to or in the course of an 6arrest, (ii) expenses incurred for medical care or treatment 7provided to a person on account of a health condition of that 8person which existed prior to the time of his or her arrest, or 9(iii) expenses for hospital inpatient services for arrestees 10enrolled for medical assistance under the Illinois Public Aid 11Code.12    If a jail or a unit of local government operating the jail 13has a contract with a pharmacy benefit manager or a contract 14with an insurance company, health maintenance organization, 15limited health service organization, administrative services 16organization, or any other managed care organization or health 17insurance issuer where a pharmacy benefit manager administers 18coverage of, payment for, or formulary design for drugs 19necessary to safeguard the life or health of any person in 20custody, that contract and the pharmacy benefit manager's 21activities shall be subject to Article XXXIIB of the Illinois 22Insurance Code and the authority of the Director of Insurance 23to enforce such provisions. The jail or unit of local 24government shall have all the rights of a plan sponsor under 25those provisions. 26(Source: P.A. 103-745, eff. 1-1-25.)   10400SB1390sam001- 56 -LRB104 08735 BAB 23976 a1    Section 99. Effective date. This Act takes effect on 2January 1, 2026, except that this Section and the changes to 3Section 513b3 of the Illinois Insurance Code take effect upon 4becoming law.".


================================================================================

Raw Text:
Full Text of SB1390 ILGA.GOV SB1390 - 104th General Assembly Sen. David KoehlerFiled: 3/17/2025   10400SB1390sam001LRB104 08735 BAB 23976 a1AMENDMENT TO SENATE BILL 13902    AMENDMENT NO. ______. Amend Senate Bill 1390 by replacing 3everything after the enacting clause with the following: 4    "Section 1. This Act may be referred to as the 5Prescription Drug Affordability Act. 6    Section 5. The State Employees Group Insurance Act of 1971 7is amended by changing Section 6.11 as follows: 8    (5 ILCS 375/6.11)9    Sec. 6.11. Required health benefits; Illinois Insurance 10Code requirements. The program of health benefits shall 11provide the post-mastectomy care benefits required to be 12covered by a policy of accident and health insurance under 13Section 356t of the Illinois Insurance Code. The program of 14health benefits shall provide the coverage required under 15Sections 356g, 356g.5, 356g.5-1, 356m, 356q, 356u, 356u.10,   10400SB1390sam001- 2 -LRB104 08735 BAB 23976 a1356w, 356x, 356z.2, 356z.4, 356z.4a, 356z.5, 356z.6, 356z.8, 2356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 3356z.17, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 4356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 5356z.51, 356z.53, 356z.54, 356z.55, 356z.56, 356z.57, 356z.59, 6356z.60, 356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 7356z.70, and 356z.71, 356z.74, 356z.76, and 356z.77 of the 8Illinois Insurance Code. The program of health benefits must 9comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and 10370c.1 and Article XXXIIB of the Illinois Insurance Code. The 11program of health benefits shall provide the coverage required 12under Section 356m of the Illinois Insurance Code and, for the 13employees of the State Employee Group Insurance Program only, 14the coverage as also provided in Section 6.11B of this Act. The 15Department of Insurance shall enforce the requirements of this 16Section with respect to Sections 370c and 370c.1 and Article 17XXXIIB of the Illinois Insurance Code; all other requirements 18of this Section shall be enforced by the Department of Central 19Management Services.20    Rulemaking authority to implement Public Act 95-1045, if 21any, is conditioned on the rules being adopted in accordance 22with all provisions of the Illinois Administrative Procedure 23Act and all rules and procedures of the Joint Committee on 24Administrative Rules; any purported rule not so adopted, for 25whatever reason, is unauthorized. 26(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22;   10400SB1390sam001- 3 -LRB104 08735 BAB 23976 a1102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 21-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-768, 3eff. 1-1-24; 102-804, eff. 1-1-23; 102-813, eff. 5-13-22; 4102-816, eff. 1-1-23; 102-860, eff. 1-1-23; 102-1093, eff. 51-1-23; 102-1117, eff. 1-13-23; 103-8, eff. 1-1-24; 103-84, 6eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, eff. 1-1-24; 7103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 103-551, eff. 88-11-23; 103-605, eff. 7-1-24; 103-718, eff. 7-19-24; 103-751, 9eff. 8-2-24; 103-870, eff. 1-1-25; 103-914, eff. 1-1-25; 10103-918, eff. 1-1-25; 103-951, eff. 1-1-25; 103-1024, eff. 111-1-25; revised 11-26-24.) 12    Section 10. The School Code is amended by changing Section 1310-22.3f as follows: 14    (105 ILCS 5/10-22.3f)15    Sec. 10-22.3f. Required health benefits. Insurance 16protection and benefits for employees shall provide the 17post-mastectomy care benefits required to be covered by a 18policy of accident and health insurance under Section 356t and 19the coverage required under Sections 356g, 356g.5, 356g.5-1, 20356m, 356q, 356u, 356u.10, 356w, 356x, 356z.4, 356z.4a, 21356z.6, 356z.8, 356z.9, 356z.11, 356z.12, 356z.13, 356z.14, 22356z.15, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 23356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 24356z.51, 356z.53, 356z.54, 356z.56, 356z.57, 356z.59, 356z.60,   10400SB1390sam001- 4 -LRB104 08735 BAB 23976 a1356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 356z.70, and 2356z.71, 356z.74, and 356z.77 of the Illinois Insurance Code. 3Insurance policies shall comply with Section 356z.19 of the 4Illinois Insurance Code. The coverage shall comply with 5Sections 155.22a, 355b, and 370c and Article XXXIIB of the 6Illinois Insurance Code. The Department of Insurance shall 7enforce the requirements of this Section. 8    Rulemaking authority to implement Public Act 95-1045, if 9any, is conditioned on the rules being adopted in accordance 10with all provisions of the Illinois Administrative Procedure 11Act and all rules and procedures of the Joint Committee on 12Administrative Rules; any purported rule not so adopted, for 13whatever reason, is unauthorized. 14(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 15102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 161-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-804, 17eff. 1-1-23; 102-813, eff. 5-13-22; 102-816, eff. 1-1-23; 18102-860, eff. 1-1-23; 102-1093, eff. 1-1-23; 102-1117, eff. 191-13-23; 103-84, eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, 20eff. 1-1-24; 103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 21103-551, eff. 8-11-23; 103-605, eff. 7-1-24; 103-718, eff. 227-19-24; 103-751, eff. 8-2-24; 103-914, eff. 1-1-25; 103-918, 23eff. 1-1-25; 103-1024, eff. 1-1-25; revised 11-26-24.) 24    Section 15. The Illinois Insurance Code is amended by 25changing Sections 513b1 and 513b3 and by adding Section   10400SB1390sam001- 5 -LRB104 08735 BAB 23976 a1513b1.1 as follows: 2    (215 ILCS 5/513b1)3    Sec. 513b1. Pharmacy benefit manager contracts.4    (a) As used in this Section: 5    "340B drug discount program" means the program established 6under Section 340B of the federal Public Health Service Act, 742 U.S.C. 256b. 8    "340B entity" means a covered entity as defined in 42 9U.S.C. 256b(a)(4) authorized to participate in the 340B drug 10discount program. 11    "340B pharmacy" means any pharmacy used to dispense 340B 12drugs for a covered entity, whether entity-owned or external.13    "Affiliate" means a person or entity that directly or 14indirectly through one or more intermediaries controls or is 15controlled by, or is under common control with, the person or 16entity specified.17    "Biological product" has the meaning ascribed to that term 18in Section 19.5 of the Pharmacy Practice Act.19    "Brand name drug" means a drug that has been approved 20under 42 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 21marketed, sold, or distributed under a proprietary, 22trademark-protected name.23    "Complex or chronic medical condition" means a physical, 24behavioral, or developmental condition that has no known cure, 25is progressive, or can be debilitating or fatal if unmanaged   10400SB1390sam001- 6 -LRB104 08735 BAB 23976 a1or untreated.2    "Covered individual" means a member, participant, 3enrollee, contract holder, policyholder, or beneficiary of a 4health benefit plan who is provided a drug benefit by the 5health benefit plan.6    "Critical access pharmacy" means a critical access care 7pharmacy as defined in Section 5-5.12b of the Illinois Public 8Aid Code.9    "Drugs" has the meaning ascribed to that term in Section 3 10of the Pharmacy Practice Act and includes biological products.11    "Generic drug" means a drug that has been approved under 1242 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 13marketed, sold, or distributed directly or indirectly to the 14retail class of trade with labeling, packaging (other than 15repackaging as the listed drug in blister packs, unit doses, 16or similar packaging for use in institutions), product code, 17labeler code, trade name, or trademark that differs from that 18of the brand name drug.19    "Health benefit plan" means a policy, contract, 20certificate, or agreement entered into, offered, or issued by 21an insurer to provide, deliver, arrange for, pay for, or 22reimburse any of the costs of physical, mental, or behavioral 23health care services. Notwithstanding Sections 122-1 through 24122-4 of this Code, "health benefit plan" includes self-funded 25employee welfare benefit plans.26    "Maximum allowable cost" means the maximum amount that a   10400SB1390sam001- 7 -LRB104 08735 BAB 23976 a1pharmacy benefit manager will reimburse a pharmacy for the 2cost of a drug. 3    "Maximum allowable cost list" means a list of drugs for 4which a maximum allowable cost has been established by a 5pharmacy benefit manager. 6    "Pharmacy benefit manager" means a person, business, or 7entity, including a wholly or partially owned or controlled 8subsidiary of a pharmacy benefit manager, that provides claims 9processing services or other prescription drug or device 10services, or both, for health benefit plans.11    "Pharmacy services" means the provision of any services 12listed within the definition of "practice of pharmacy" under 13subsection (d) of Section 3 of the Pharmacy Practice Act.14    "Rare medical condition" means a physical, behavioral, or 15developmental condition that affects fewer than 200,000 16individuals in the United States or approximately 1 in 1,500 17individuals worldwide.18    "Rebate aggregator" means a person or entity, including 19group purchasing organizations, that negotiate rebates or 20other fees with drug manufacturers on behalf or for the 21benefit of a pharmacy benefit manager or its client and may 22also be involved in contracts that entitle the rebate 23aggregator or its client to receive rebates or other fees from 24drug manufacturers based on drug utilization or 25administration. 26    "Retail price" means the price an individual without   10400SB1390sam001- 8 -LRB104 08735 BAB 23976 a1prescription drug coverage would pay at a retail pharmacy, not 2including a pharmacist dispensing fee. 3    "Specialty drug" means a drug that:4        (1) is prescribed for a person with a complex or 5    chronic medical condition or a rare medical condition;6        (2) has limited or exclusive distribution; and7        (3) requires both:8            (A) specialized product handling by the dispensing 9        pharmacy or administration by the dispensing pharmacy; 10        and11            (B) specialized clinical care, including frequent 12        dosing adjustments, intensive clinical monitoring, or 13        expanded services for patients, including intensive 14        patient counseling, education, or ongoing clinical 15        support beyond traditional dispensing activities, such 16        as individualized disease and therapy management to 17        support improved health outcomes.18    "Spread pricing" means the model of drug pricing in which 19the pharmacy benefit manager charges a health benefit plan a 20contracted price for drugs, and the contracted price for the 21drugs differs from the amount the pharmacy benefit manager 22directly or indirectly pays the pharmacist or pharmacy for the 23drugs, pharmacist services, or drug and dispensing fees.24    "Steer" includes, but is not limited to:25        (1) requiring a covered individual to use only a 26    pharmacy, including a mail-order or specialty pharmacy, in   10400SB1390sam001- 9 -LRB104 08735 BAB 23976 a1    which the pharmacy benefit manager or its affiliate 2    maintains an ownership interest or control;3        (2) offering or implementing a plan design that 4    encourages a covered individual to use a pharmacy in which 5    the pharmacy benefit manager or an affiliate maintains an 6    ownership interest or control, if such plan design 7    increases costs for the covered individual. This includes 8    a plan design that requires a covered individual to pay 9    higher costs or an increased share of costs for a drug or 10    drug-related service if the covered individual uses a 11    pharmacy that is not owned or controlled by the pharmacy 12    benefit manager or its affiliate.13        (3) reimbursing a pharmacy or pharmacist for a drug 14    and pharmacist service in an amount less than the amount 15    that the pharmacy benefit manager reimburses itself or an 16    affiliate, including affiliated manufacturers or joint 17    ventures for providing the same drug or service. 18    "Third-party payer" means any entity that pays for 19prescription drugs on behalf of a patient other than a health 20care provider or sponsor of a plan subject to regulation under 21Medicare Part D, 42 U.S.C. 1395w-101 et seq.22    (a-5) In this Article, references to an "insurer" or 23"health insurer" shall include commercial private health 24insurance issuers, managed care organizations, managed care 25community networks, and any other third-party payer that 26contracts with pharmacy benefit managers or with the   10400SB1390sam001- 10 -LRB104 08735 BAB 23976 a1Department of Healthcare and Family Services to provide 2benefits or services under the Medicaid program or to 3otherwise engage in the administration or payment of pharmacy 4benefits. However, the terms do not refer to the plan sponsor 5of a self-funded, single-employer employee welfare benefit 6plan subject to 29 U.S.C. 1144.7    (b) A contract between a health insurer and a pharmacy 8benefit manager must require that the pharmacy benefit 9manager: 10        (1) Update maximum allowable cost pricing information 11    at least every 7 calendar days. 12        (2) Maintain a process that will, in a timely manner, 13    eliminate drugs from maximum allowable cost lists or 14    modify drug prices to remain consistent with changes in 15    pricing data used in formulating maximum allowable cost 16    prices and product availability. 17        (3) Provide access to its maximum allowable cost list 18    to each pharmacy or pharmacy services administrative 19    organization subject to the maximum allowable cost list. 20    Access may include a real-time pharmacy website portal to 21    be able to view the maximum allowable cost list. As used in 22    this Section, "pharmacy services administrative 23    organization" means an entity operating within the State 24    that contracts with independent pharmacies to conduct 25    business on their behalf with third-party payers. A 26    pharmacy services administrative organization may provide   10400SB1390sam001- 11 -LRB104 08735 BAB 23976 a1    administrative services to pharmacies and negotiate and 2    enter into contracts with third-party payers or pharmacy 3    benefit managers on behalf of pharmacies. 4        (4) Provide a process by which a contracted pharmacy 5    can appeal the provider's reimbursement for a drug subject 6    to maximum allowable cost pricing. The appeals process 7    must, at a minimum, include the following: 8            (A) A requirement that a contracted pharmacy has 9        14 calendar days after the applicable fill date to 10        appeal a maximum allowable cost if the reimbursement 11        for the drug is less than the net amount that the 12        network provider paid to the supplier of the drug. 13            (B) A requirement that a pharmacy benefit manager 14        must respond to a challenge within 14 calendar days of 15        the contracted pharmacy making the claim for which the 16        appeal has been submitted.17            (C) A telephone number and e-mail address or 18        website to network providers, at which the provider 19        can contact the pharmacy benefit manager to process 20        and submit an appeal.21            (D) A requirement that, if an appeal is denied, 22        the pharmacy benefit manager must provide the reason 23        for the denial and the name and the national drug code 24        number from national or regional wholesalers.25            (E) A requirement that, if an appeal is sustained, 26        the pharmacy benefit manager must make an adjustment   10400SB1390sam001- 12 -LRB104 08735 BAB 23976 a1        in the drug price effective the date the challenge is 2        resolved and make the adjustment applicable to all 3        similarly situated network pharmacy providers, as 4        determined by the managed care organization or 5        pharmacy benefit manager. 6        (5) Allow a plan sponsor or insurer whose coverage is 7    administered by the contracting with a pharmacy benefit 8    manager an annual right to audit compliance with the terms 9    of the contract by the pharmacy benefit manager, 10    including, but not limited to, full disclosure of any and 11    all rebate amounts secured, whether product specific or 12    generalized rebates, that were provided to the pharmacy 13    benefit manager by a pharmaceutical manufacturer. The cost 14    of the audit shall be borne exclusively by the pharmacy 15    benefit manager. 16        (6) Allow a plan sponsor or insurer whose coverage is 17    administered by the contracting with a pharmacy benefit 18    manager to request that the pharmacy benefit manager 19    disclose the actual amounts paid by the pharmacy benefit 20    manager to the pharmacy.21        (7) Provide notice to the plan sponsor or the insurer 22    party contracting with the pharmacy benefit manager of any 23    consideration that the pharmacy benefit manager receives 24    from the manufacturer for dispense as written 25    prescriptions once a generic or biologically similar 26    product becomes available.   10400SB1390sam001- 13 -LRB104 08735 BAB 23976 a1    (c) In order to place a particular prescription drug on a 2maximum allowable cost list, the pharmacy benefit manager 3must, at a minimum, ensure that: 4        (1) if the drug is a generically equivalent drug, it 5    is listed as therapeutically equivalent and 6    pharmaceutically equivalent "A" or "B" rated in the United 7    States Food and Drug Administration's most recent version 8    of the "Orange Book" or have an NR or NA rating by 9    Medi-Span, Gold Standard, or a similar rating by a 10    nationally recognized reference; 11        (2) the drug is available for purchase by each 12    pharmacy in the State from national or regional 13    wholesalers operating in Illinois; and 14        (3) the drug is not obsolete. 15    (d) A pharmacy benefit manager is prohibited from limiting 16a pharmacist's ability to disclose whether the cost-sharing 17obligation exceeds the retail price for a covered prescription 18drug, and the availability of a more affordable alternative 19drug, if one is available in accordance with Section 42 of the 20Pharmacy Practice Act. 21    (e) A health insurer or pharmacy benefit manager shall not 22require a covered individual an insured to make a payment for a 23prescription drug at the point of sale in an amount that 24exceeds the lesser of: 25        (1) the applicable cost-sharing amount; or26        (2) the retail price of the drug in the absence of   10400SB1390sam001- 14 -LRB104 08735 BAB 23976 a1    prescription drug coverage;2        (3) the discounted price available through a no cost 3    drug program or drug manufacturer voucher provided by or 4    for the covered individual at the point of sale; or5        (4) the discounted price available through a 6    discounted health care services plan provided by or for 7    the covered individual at the point of sale. 8    (f) Unless required by law, a contract between a pharmacy 9benefit manager or third-party payer and a 340B entity or 340B 10pharmacy shall not contain any provision that: 11        (1) distinguishes between drugs purchased through the 12    340B drug discount program and other drugs when 13    determining reimbursement or reimbursement methodologies, 14    or contains otherwise less favorable payment terms or 15    reimbursement methodologies for 340B entities or 340B 16    pharmacies when compared to similarly situated non-340B 17    entities; 18        (2) imposes any fee, chargeback, or rate adjustment 19    that is not similarly imposed on similarly situated 20    pharmacies that are not 340B entities or 340B pharmacies; 21        (3) imposes any fee, chargeback, or rate adjustment 22    that exceeds the fee, chargeback, or rate adjustment that 23    is not similarly imposed on similarly situated pharmacies 24    that are not 340B entities or 340B pharmacies; 25        (4) prevents or interferes with an individual's choice 26    to receive a covered prescription drug from a 340B entity   10400SB1390sam001- 15 -LRB104 08735 BAB 23976 a1    or 340B pharmacy through any legally permissible means, 2    except that nothing in this paragraph shall prohibit the 3    establishment of differing copayments or other 4    cost-sharing amounts within the health benefit plan for 5    covered individuals persons who acquire covered 6    prescription drugs from a nonpreferred or nonparticipating 7    provider; 8        (5) excludes a 340B entity or 340B pharmacy from a 9    pharmacy network on any basis that includes consideration 10    of whether the 340B entity or 340B pharmacy participates 11    in the 340B drug discount program; 12        (6) prevents a 340B entity or 340B pharmacy from using 13    a drug purchased under the 340B drug discount program; or 14        (7) any other provision that discriminates against a 15    340B entity or 340B pharmacy by treating the 340B entity 16    or 340B pharmacy differently than non-340B entities or 17    non-340B pharmacies for any reason relating to the 18    entity's participation in the 340B drug discount program. 19    As used in this subsection, "pharmacy benefit manager" and 20"third-party payer" do not include pharmacy benefit managers 21and third-party payers acting on behalf of a Medicaid program.22    (f-5) A pharmacy benefit manager or an affiliate acting on 23its behalf shall not conduct spread pricing.24    (f-10) A pharmacy benefit manager or an affiliate acting 25on its behalf shall not steer a covered individual.26    (f-15) A pharmacy benefit manager or rebate aggregator   10400SB1390sam001- 16 -LRB104 08735 BAB 23976 a1must remit no less than 90% of any amounts paid by a 2pharmaceutical manufacturer, wholesaler, or other distributor 3of a drug, including, but not limited to, rebates, group 4purchasing fees, and other fees, to the health benefit plan 5sponsor, covered individual, or employer. Records of rebates 6and fees remitted from the pharmacy benefit manager or rebate 7aggregator must be disclosed to the Department annually in a 8format to be specified by the Department.9    (f-20) A pharmacy benefit manager must not reimburse a 10critical access pharmacy for a drug or pharmacy service in an 11amount less than the national average drug acquisition cost 12for the drug or pharmacy service at the time the drug is 13administered or dispensed, plus the current Medicaid critical 14access pharmacy dispensing fee. If the national average drug 15acquisition cost is not available at the time a drug is 16administered or dispensed, a pharmacy benefit manager must not 17reimburse a critical access pharmacy for any drug at a rate 18that is less than the amount established by the Department of 19Healthcare and Family Services for the drug or service under 20the Medicaid program, as set forth in the applicable 21administrative rule, plus the current Medicaid critical access 22pharmacy dispensing fee.23    (f-25) A pharmacy benefit manager or an affiliate acting 24on its behalf is prohibited from limiting a covered 25individual's access to drugs from a pharmacy or pharmacist 26enrolled with the health benefit plan under the terms offered   10400SB1390sam001- 17 -LRB104 08735 BAB 23976 a1to all pharmacies in the plan coverage area, including by 2designating the covered drug as a specialty drug contrary to 3the definition in this Section.4    (f-30) The contract between the pharmacy benefit manager 5and the insurer or health benefit plan sponsor must allow and 6provide for the pharmacy benefit manager's compliance with an 7audit at least once per calendar year of the rebate and fee 8records remitted from a pharmacy benefit manager or its 9affiliated party to a health benefit plan. This audit may be 10incorporated into the audit under paragraph (5) of subsection 11(b) of this Section. Contracts with rebate aggregators, 12pharmacy services administrative organizations, pharmacies, or 13drug manufacturers must be available for audit by health 14benefit plan sponsors, insurers, or their designees at least 15once per plan year. Audits shall be performed by an auditor 16selected by the health benefit plan sponsor, insurer, or its 17designee. Health benefit plan sponsors and insurers shall give 18the pharmacy benefit manager a complete copy of the audit and 19the pharmacy benefit manager shall provide a complete copy of 20those findings to the Department within 60 days of initial 21receipt. Rebate contracts with rebate aggregators, pharmacy 22services administrative organizations, pharmacies, or drug 23manufacturers shall be available for audit by health benefit 24plan sponsor, insurer, or designee. Nothing in this Section 25shall limit the Department's ability to access the books and 26records and any and all copies thereof of pharmacy benefit   10400SB1390sam001- 18 -LRB104 08735 BAB 23976 a1managers, their affiliates, or affiliated rebate aggregators. 2    (g) A violation of this Section by a pharmacy benefit 3manager constitutes an unfair or deceptive act or practice in 4the business of insurance under Section 424. 5    (h) A provision that violates subsection (f) in a contract 6between a pharmacy benefit manager or a third-party payer and 7a 340B entity that is entered into, amended, or renewed after 8July 1, 2022 shall be void and unenforceable. This subsection 9and subsection (f) do not apply to a contract between a 340B 10entity and the plan sponsor of a self-funded, single-employer 11employee welfare benefit plan subject to 29 U.S.C. 1144. 12    (i)(1) A pharmacy benefit manager may not retaliate 13against a pharmacist or pharmacy for disclosing information in 14a court, in an administrative hearing, before a legislative 15commission or committee, or in any other proceeding, if the 16pharmacist or pharmacy has reasonable cause to believe that 17the disclosed information is evidence of a violation of a 18State or federal law, rule, or regulation.19    (2) A pharmacy benefit manager may not retaliate against a 20pharmacist or pharmacy for disclosing information to a 21government or law enforcement agency, if the pharmacist or 22pharmacy has reasonable cause to believe that the disclosed 23information is evidence of a violation of a State or federal 24law, rule, or regulation.25    (3) A pharmacist or pharmacy shall make commercially 26reasonable efforts to limit the disclosure of confidential and   10400SB1390sam001- 19 -LRB104 08735 BAB 23976 a1proprietary information.2    (4) Retaliatory actions against a pharmacy or pharmacist 3include cancellation of, restriction of, or refusal to renew 4or offer a contract to a pharmacy solely because the pharmacy 5or pharmacist has:6        (A) made disclosures of information that the 7    pharmacist or pharmacy has reasonable cause to believe is 8    evidence of a violation of a State or federal law, rule, or 9    regulation;10        (B) filed complaints with the plan or pharmacy benefit 11    manager; or12        (C) filed complaints against the plan or pharmacy 13    benefit manager with the Department.14    (j) This Section applies to contracts entered into or 15renewed on or after July 1, 2022 and, unless provided 16otherwise in this Section or in the Illinois Public Aid Code, 17applies to pharmacy benefit managers that are contracted with 18a Medicaid managed care entity on or after January 1, 2026. 19    (k) This Section applies to any health benefit group or 20individual policy of accident and health insurance or managed 21care plan that provides coverage for prescription drugs and 22that is amended, delivered, issued, or renewed on or after 23July 1, 2020. The changes made to this Section by this 24amendatory Act of the 104th General Assembly shall apply with 25respect to any health benefit plan that provides coverage for 26drugs that is amended, delivered, issued, or renewed on or   10400SB1390sam001- 20 -LRB104 08735 BAB 23976 a1after January 1, 2026. 2    (l) A pharmacy benefit manager is responsible for 3compliance with all State requirements applicable to pharmacy 4benefit managers even if an action or responsibility of a 5pharmacy benefit manager is delegated to or completed by a 6third party with an affiliation or a direct or indirect 7contractual relationship. 8(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; 9103-453, eff. 8-4-23.) 10    (215 ILCS 5/513b1.1 new)11    Sec. 513b1.1. Pharmacy benefit manager reporting 12requirements.13    (a) A pharmacy benefit manager that provides services for 14a health benefit plan must submit an annual report no later 15than September 1, to the Department, each health benefit plan 16sponsor, and each insurer that includes the following:17        (1) data on the health benefit plan including:18            (A) a list of drugs including corresponding 19        information on therapeutic class, brand name, generic 20        name, or specialty drug name;21            (B) number of covered individuals;22            (C) number of drug-related claims;23            (D) dosage units;24            (E) dispensing channel used;25            (F) wholesale acquisition cost per drug; and  10400SB1390sam001- 21 -LRB104 08735 BAB 23976 a1            (G) total out-of-pocket spending by deidentified 2        covered individual per drug, per transaction;3        (2) amount received by the health benefit plan in 4    rebates, fees, or discounts related to drug utilization or 5    spending;6        (3) total gross spending on drugs by the health 7    benefit plan;8        (4) total net spending, gross spending less 9    administrative portion of the medical loss ratio, spread 10    pricing, on drugs by the health benefit plan;11        (5) the amount paid by the health benefit plan to the 12    pharmacy benefit manager for reimbursement cost of a drug 13    and service per transaction;14        (6) the amount a pharmacy benefit manager paid for 15    pharmacists' services and drugs rendered related to the 16    health benefit plan per transaction, including, but not 17    limited to, any dispensing fee;18        (7) the specific rebate amount received by the 19    pharmacy benefit manager per transaction, the amount of 20    the rebates passed through to the health benefit plan per 21    transaction, and the amount of the rebates passed on to 22    covered individuals at the point of sale that reduced the 23    covered individuals' applicable deductible, copayment, 24    coinsurance, or other cost-sharing amount per transaction;25        (8) any information collected from drug manufacturers 26    pertaining to copayment assistance;  10400SB1390sam001- 22 -LRB104 08735 BAB 23976 a1        (9) any compensation paid to brokers, consultants, 2    advisors, or any other individual or firm for referrals, 3    consideration, or retention by the health benefit plan;4        (10) explanation of benefit design parameters 5    encouraging or requiring covered individuals to use 6    affiliated pharmacies, percentage of drugs charged by 7    these pharmacies, and a list of drugs dispensed by 8    affiliated pharmacies with their associated costs; and9        (11) a complete copy of each unredacted contract the 10    pharmacy benefit manager has with the health benefit plan 11    sponsor or insurer.12    (b) Annual reports pursuant to subsection (a):13        (1) must be written in plain language to ensure ease 14    of reading and accessibility.15        (2) must only contain summary health information to 16    ensure plan, coverage, or covered individual information 17    remains private and confidential.18        (3) upon request by a covered individual, must be 19    available in summary format and provide aggregated 20    information to help covered individuals understand their 21    health benefit plan's drug coverage.22        (4) must be filed with the Department no later than 23    September 1 of each year via the Systems for Electronic 24    Rates & Forms Filing (SERFF). The filing shall include the 25    summary version of the report described in paragraph (3) 26    of this subsection, which shall be marked for public   10400SB1390sam001- 23 -LRB104 08735 BAB 23976 a1    access.2    (c) A pharmacy benefit manager may petition the Department 3for a filing submission extension. The Director may grant or 4deny the extension within 5 business days.5    (d) Failure by a pharmacy benefit manager to submit all 6required elements in an annual report to the Department may 7result in a fine levied by the Director not to exceed $10,000 8per day, per offense. Funds derived from fines levied shall be 9deposited into the Insurance Producer Administration Fund. 10Fine information shall be posted on the Department's website.11    (e) A pharmacy benefit manager found in violation of 12subsection (a) or paragraph (4) of subsection (b) may request 13a hearing from the Director within 10 days of receipt of the 14Director's order, or, if the violation is found in a market 15conduct examination, as provided in Section 132 of this Code.16    (f) Except for the summary version, the annual reports 17submitted by pharmacy benefit managers shall be considered 18confidential and privileged for all purposes, including for 19purposes of the Freedom of Information Act, shall not be 20subject to subpoena from any private party, and shall not be 21admissible as evidence in a civil action.22    (g) A copy of an adverse decision against a pharmacy 23benefit manager for failing to submit an annual report to the 24Department must be posted to the Department's website.25    (h) Nothing in this Section shall be construed as 26permitting a pharmacy benefit manager to avoid or otherwise   10400SB1390sam001- 24 -LRB104 08735 BAB 23976 a1fail to comply with the reporting requirements set forth in 2Section 5-36 of the Illinois Public Aid Code. 3    (215 ILCS 5/513b3)4    Sec. 513b3. Examination. 5    (a) The Director, or his or her designee, may examine a 6registered pharmacy benefit manager related to all of its 7lines of business, including government programs, under the 8Director's jurisdiction in accordance with Sections 132-132.7. 9If the Director or the examiners find that the pharmacy 10benefit manager has violated this Article or any other 11insurance-related or health benefits-related laws, rules, or 12regulations under the Director's jurisdiction because of the 13manner in which the pharmacy benefit manager has conducted 14business on behalf of a health insurer or plan sponsor, then, 15unless the health insurer or plan sponsor is included in the 16examination and has been afforded the same opportunity to 17request or participate in a hearing on the examination report, 18the examination report shall not allege a violation by the 19health insurer or plan sponsor and the Director's order based 20on the report shall not impose any requirements, prohibitions, 21or penalties on the health insurer or plan sponsor. Nothing in 22this Section shall prevent the Director from using any 23information obtained during the examination of an 24administrator to examine, investigate, or take other 25appropriate regulatory or legal action with respect to a   10400SB1390sam001- 25 -LRB104 08735 BAB 23976 a1health insurer or plan sponsor.2    (b) The examination requirement for the pharmacy benefit 3manager to provide convenient and free access to all books and 4records under Sections 132 and 132.4 of this Code includes, at 5the Director's discretion, unredacted copies furnished 6electronically to the Director's market conduct surveillance 7personnel or examiners. Access must include information 8related to third-party entities affiliated or contracted with 9the pharmacy benefit manager, including, but not limited, to, 10rebate aggregators and pharmacy services administrative 11organizations. 12(Source: P.A. 103-897, eff. 1-1-25.) 13    Section 20. The Illinois Public Aid Code is amended by 14changing Sections 5-5.12b and 5-36 as follows: 15    (305 ILCS 5/5-5.12b)16    Sec. 5-5.12b. Critical access care pharmacy program.17    (a) As used in this Section: 18    "Critical access care pharmacy" means an Illinois-based 19brick and mortar pharmacy that is located in Illinois that is 20owned by a person or entity with an ownership or control 21interest in a county with fewer than 50,000 residents and that 22owns fewer than 10 pharmacies, and is either located in a 23county with fewer than 50,000 residents or in a county with 2450,000 or more residents and in an area within Illinois that is   10400SB1390sam001- 26 -LRB104 08735 BAB 23976 a1designated as a Medically Underserved Area by the Health 2Resources and Services Administration, an agency of the U.S. 3Department of Health and Human Services, or at the discretion 4of the Department of Healthcare and Family Services, as set 5forth in administrative rule. 6    "Critical access care pharmacy program payment" means the 7number of individual prescriptions a critical access care 8pharmacy fills during that quarter multiplied by the lesser of 9the individual payment amount or the dispensing reimbursement 10rate made by the Department under the medical assistance 11program as of April 1, 2018. 12    "Individual payment amount" means the dividend of 1/4 of 13the annual amount appropriated for the critical access care 14pharmacy program by the number of prescriptions filled by all 15critical access care pharmacies reimbursed by Medicaid managed 16care organizations that quarter. 17    (b) Subject to appropriations, the Department shall 18establish a critical access care pharmacy program to ensure 19the sustainability of critical access pharmacies throughout 20the State of Illinois. 21    (c) The critical access care pharmacy program shall not 22exceed $10,000,000 annually and individual payment amounts per 23prescription shall not exceed the dispensing rate that the 24Department would have reimbursed under the Medical Assistance 25Program as of April 1, 2018. 26    (d) Quarterly, the Department shall determine the number   10400SB1390sam001- 27 -LRB104 08735 BAB 23976 a1of prescriptions filled by critical access care pharmacies 2reimbursed by Medicaid managed care organizations utilizing 3encounter data available to the Department. The Department 4shall determine the individual payment amount per prescription 5by dividing 1/4 of the annual amount appropriated for the 6critical access care pharmacy program by the number of 7prescriptions filled by all critical access care pharmacies 8reimbursed by Medicaid managed care organizations that 9quarter. If the individual payment amount per prescription as 10calculated using quarterly prescription amounts exceeds the 11reimbursement rate under the medical assistance program as of 12April 1, 2018, then the individual payment amount per 13prescription shall be the dispensing reimbursement rate under 14the medical assistance program as of April 1, 2018. 15    (e) Quarterly, the Department shall distribute to critical 16access care pharmacies a critical access care pharmacy program 17payment. The first payment shall be calculated utilizing the 18encounter data from the last quarter of State fiscal year 192018.20    (f) The Department may adopt rules permitting an 21Illinois-based brick and mortar pharmacy that owns fewer than 2210 pharmacies to receive critical access care pharmacy program 23payments in the same manner as a critical access care 24pharmacy, regardless of whether the pharmacy is located in a 25county with a population of less than 50,000. 26(Source: P.A. 100-587, eff. 6-4-18.)   10400SB1390sam001- 28 -LRB104 08735 BAB 23976 a1    (305 ILCS 5/5-36)2    Sec. 5-36. Pharmacy benefits. 3    (a)(1) The Department may enter into a contract with a 4third party on a fee-for-service reimbursement model for the 5purpose of administering pharmacy benefits as provided in this 6Section for members not enrolled in a Medicaid managed care 7organization; however, these services shall be approved by the 8Department. The Department shall ensure coordination of care 9between the third-party administrator and managed care 10organizations as a consideration in any contracts established 11in accordance with this Section. Any managed care techniques, 12principles, or administration of benefits utilized in 13accordance with this subsection shall comply with State law. 14    (2) The following shall apply to contracts between 15entities contracting relating to the Department's third-party 16administrators and pharmacies: 17        (A) the Department shall approve any contract between 18    a third-party administrator and a pharmacy;19        (B) the Department's third-party administrator shall 20    not change the terms of a contract between a third-party 21    administrator and a pharmacy without written approval by 22    the Department; and23        (C) the Department's third-party administrator shall 24    not create, modify, implement, or indirectly establish any 25    fee on a pharmacy, pharmacist, or a recipient of medical   10400SB1390sam001- 29 -LRB104 08735 BAB 23976 a1    assistance without written approval by the Department. 2    (b) The provisions of this Section shall not apply to 3outpatient pharmacy services provided by a health care 4facility registered as a covered entity pursuant to 42 U.S.C. 5256b or any pharmacy owned by or contracted with the covered 6entity. A Medicaid managed care organization shall, either 7directly or through a pharmacy benefit manager, administer and 8reimburse outpatient pharmacy claims submitted by a health 9care facility registered as a covered entity pursuant to 42 10U.S.C. 256b, its owned pharmacies, and contracted pharmacies 11in accordance with the contractual agreements the Medicaid 12managed care organization or its pharmacy benefit manager has 13with such facilities and pharmacies and in accordance with 14subsection (h-5). 15    (b-5) Any pharmacy benefit manager that contracts with a 16Medicaid managed care organization to administer and reimburse 17pharmacy claims as provided in this Section must be registered 18with the Director of Insurance in accordance with Section 19513b2 of the Illinois Insurance Code. A pharmacy benefit 20manager must comply with all provisions of Article XXXIIB of 21the Illinois Insurance Code to the extent that they do not 22prevent the application of any provision of this Article or 23applicable federal law. Nothing in this Section shall be 24construed to limit the authority of the Illinois Department or 25the Inspector General to administer or enforce any provisions 26of this Section or any other Section in the Illinois Public Aid   10400SB1390sam001- 30 -LRB104 08735 BAB 23976 a1Code related to pharmacy benefit managers or Medicaid managed 2care entity. 3    (c) On at least an annual basis, the Director of the 4Department of Healthcare and Family Services shall submit a 5report beginning no later than one year after January 1, 2020 6(the effective date of Public Act 101-452) that provides an 7update on any contract, contract issues, formulary, dispensing 8fees, and maximum allowable cost concerns regarding a 9third-party administrator and managed care. The requirement 10for reporting to the General Assembly shall be satisfied by 11filing copies of the report with the Speaker, the Minority 12Leader, and the Clerk of the House of Representatives and with 13the President, the Minority Leader, and the Secretary of the 14Senate. The Department shall take care that no proprietary 15information is included in the report required under this 16Section. 17    (d) (Blank). A pharmacy benefit manager shall notify the 18Department in writing of any activity, policy, or practice of 19the pharmacy benefit manager that directly or indirectly 20presents a conflict of interest that interferes with the 21discharge of the pharmacy benefit manager's duty to a managed 22care organization to exercise its contractual duties. 23"Conflict of interest" shall be defined by rule by the 24Department.25    (e) A pharmacy benefit manager shall, upon request, 26disclose to the Department the following information:   10400SB1390sam001- 31 -LRB104 08735 BAB 23976 a1        (1) whether the pharmacy benefit manager has a 2    contract, agreement, or other arrangement with a 3    pharmaceutical manufacturer to exclusively dispense or 4    provide a drug to a managed care organization's enrollees, 5    and the aggregate amounts of consideration of economic 6    benefits collected or received pursuant to that 7    arrangement; 8        (2) the percentage of claims payments made by the 9    pharmacy benefit manager to pharmacies owned, managed, or 10    controlled by the pharmacy benefit manager or any of the 11    pharmacy benefit manager's management companies, parent 12    companies, subsidiary companies, or jointly held 13    companies; 14        (3) the aggregate amount of the fees or assessments 15    imposed on, or collected from, pharmacy providers; 16        (4) the average annualized percentage of revenue 17    collected by the pharmacy benefit manager as a result of 18    each contract it has executed with a managed care 19    organization contracted by the Department to provide 20    medical assistance benefits which is not paid by the 21    pharmacy benefit manager to pharmacy providers and 22    pharmaceutical manufacturers or labelers or in order to 23    perform administrative functions pursuant to its contracts 24    with managed care organizations; 25        (5) the total number of prescriptions dispensed under 26    each contract the pharmacy benefit manager has with a   10400SB1390sam001- 32 -LRB104 08735 BAB 23976 a1    managed care organization (MCO) contracted by the 2    Department to provide medical assistance benefits;3        (6) the aggregate wholesale acquisition cost for drugs 4    that were dispensed to enrollees in each MCO with which 5    the pharmacy benefit manager has a contract by any 6    pharmacy owned, managed, or controlled by the pharmacy 7    benefit manager or any of the pharmacy benefit manager's 8    management companies, parent companies, subsidiary 9    companies, or jointly-held companies; 10        (7) the aggregate amount of administrative fees that 11    the pharmacy benefit manager received from all 12    pharmaceutical manufacturers for prescriptions dispensed 13    to MCO enrollees; 14        (8) for each MCO with which the pharmacy benefit 15    manager has a contract, the aggregate amount of payments 16    received by the pharmacy benefit manager from the MCO; 17        (9) for each MCO with which the pharmacy benefit 18    manager has a contract, the aggregate amount of 19    reimbursements the pharmacy benefit manager paid to 20    contracting pharmacies; and 21        (10) any other information considered necessary by the 22    Department. 23    (f) The information disclosed under subsection (e) shall 24include all retail, mail order, specialty, and compounded 25prescription products. All information made available to the 26Department under subsection (e) is confidential and not   10400SB1390sam001- 33 -LRB104 08735 BAB 23976 a1subject to disclosure under the Freedom of Information Act. 2All information made available to the Department under 3subsection (e) shall not be reported or distributed in any way 4that compromises its competitive, proprietary, or financial 5value. The information shall only be used by the Department to 6assess the contract, agreement, or other arrangements made 7between a pharmacy benefit manager and a pharmacy provider, 8pharmaceutical manufacturer or labeler, managed care 9organization, or other entity, as applicable. 10    (g) A pharmacy benefit manager shall disclose directly in 11writing to a pharmacy provider or pharmacy services 12administrative organization contracting with the pharmacy 13benefit manager of any material change to a contract provision 14that affects the terms of the reimbursement, the process for 15verifying benefits and eligibility, dispute resolution, 16procedures for verifying drugs included on the formulary, and 17contract termination at least 30 days prior to the date of the 18change to the provision. The terms of this subsection shall be 19deemed met if the pharmacy benefit manager posts the 20information on a website, viewable by the public. A pharmacy 21service administration organization shall notify all contract 22pharmacies of any material change, as described in this 23subsection, within 2 days of notification. As used in this 24Section, "pharmacy services administrative organization" means 25an entity operating within the State that contracts with 26independent pharmacies to conduct business on their behalf   10400SB1390sam001- 34 -LRB104 08735 BAB 23976 a1with third-party payers. A pharmacy services administrative 2organization may provide administrative services to pharmacies 3and negotiate and enter into contracts with third-party payers 4or pharmacy benefit managers on behalf of pharmacies. 5    (h) A pharmacy benefit manager shall not include the 6following in a contract with a pharmacy provider: 7        (1) a provision prohibiting the provider from 8    informing a patient of a less costly alternative to a 9    prescribed medication; or 10        (2) a provision that prohibits the provider from 11    dispensing a particular amount of a prescribed medication, 12    if the pharmacy benefit manager allows that amount to be 13    dispensed through a pharmacy owned or controlled by the 14    pharmacy benefit manager, unless the prescription drug is 15    subject to restricted distribution by the United States 16    Food and Drug Administration or requires special handling, 17    provider coordination, or patient education that cannot be 18    provided by a retail pharmacy. 19    (h-5) Unless required by law, a Medicaid managed care 20organization or pharmacy benefit manager administering or 21managing benefits on behalf of a Medicaid managed care 22organization shall not refuse to contract with a 340B entity 23or 340B pharmacy for refusing to accept less favorable payment 24terms or reimbursement methodologies when compared to 25similarly situated non-340B entities and shall not include in 26a contract with a 340B entity or 340B pharmacy a provision   10400SB1390sam001- 35 -LRB104 08735 BAB 23976 a1that: 2        (1) imposes any fee, chargeback, or rate adjustment 3    that is not similarly imposed on similarly situated 4    pharmacies that are not 340B entities or 340B pharmacies; 5        (2) imposes any fee, chargeback, or rate adjustment 6    that exceeds the fee, chargeback, or rate adjustment that 7    is not similarly imposed on similarly situated pharmacies 8    that are not 340B entities or 340B pharmacies; 9        (3) prevents or interferes with an individual's choice 10    to receive a prescription drug from a 340B entity or 340B 11    pharmacy through any legally permissible means; 12        (4) excludes a 340B entity or 340B pharmacy from a 13    pharmacy network on the basis of whether the 340B entity 14    or 340B pharmacy participates in the 340B drug discount 15    program; 16        (5) prevents a 340B entity or 340B pharmacy from using 17    a drug purchased under the 340B drug discount program so 18    long as the drug recipient is a patient of the 340B entity; 19    nothing in this Section exempts a 340B pharmacy from 20    following the Department's preferred drug list or from any 21    prior approval requirements of the Department or the 22    Medicaid managed care organization that are imposed on the 23    drug for all pharmacies; or 24        (6) any other provision that discriminates against a 25    340B entity or 340B pharmacy by treating a 340B entity or 26    340B pharmacy differently than non-340B entities or   10400SB1390sam001- 36 -LRB104 08735 BAB 23976 a1    non-340B pharmacies for any reason relating to the 2    entity's participation in the 340B drug discount program. 3    A provision that violates this subsection in any contract 4between a Medicaid managed care organization or its pharmacy 5benefit manager and a 340B entity entered into, amended, or 6renewed after July 1, 2022 shall be void and unenforceable. 7    In this subsection (h-5):8    "340B entity" means a covered entity as defined in 42 9U.S.C. 256b(a)(4) authorized to participate in the 340B drug 10discount program.11    "340B pharmacy" means any pharmacy used to dispense 340B 12drugs for a covered entity, whether entity-owned or external. 13    (i) Nothing in this Section shall be construed to prohibit 14a pharmacy benefit manager from requiring the same 15reimbursement and terms and conditions for a pharmacy provider 16as for a pharmacy owned, controlled, or otherwise associated 17with the pharmacy benefit manager. 18    (j) A pharmacy benefit manager shall establish and 19implement a process for the resolution of disputes arising out 20of this Section, which shall be approved by the Department. 21    (k) The Department shall adopt rules establishing 22reasonable dispensing fees for fee-for-service payments in 23accordance with guidance or guidelines from the federal 24Centers for Medicare and Medicaid Services.25(Source: P.A. 102-558, eff. 8-20-21; 102-778, eff. 7-1-22; 26103-593, eff. 6-7-24.)   10400SB1390sam001- 37 -LRB104 08735 BAB 23976 a1    Section 25. The Juvenile Court Act of 1987 is amended by 2changing Section 5-515 as follows: 3    (705 ILCS 405/5-515)4    Sec. 5-515. Medical, and dental, and pharmaceutical 5treatment and care. 6    (a) At all times during temporary custody, detention or 7shelter care, the court may authorize a physician, a hospital 8or any other appropriate health care provider to provide 9medical, dental or surgical procedures or pharmaceuticals if 10those procedures or pharmaceuticals are necessary to safeguard 11the minor's life or health. If the minor is covered under an 12existing medical or dental plan, the county shall be 13reimbursed for the expenses incurred for such services as if 14the minor were not held in temporary custody, detention, or 15shelter care.16    (b) If a provider of temporary custody, detention, or 17shelter care has a contract with a pharmacy benefit manager or 18a contract with an insurance company, health maintenance 19organization, limited health service organization, 20administrative services organization, or any other managed 21care organization or health insurance issuer where a pharmacy 22benefit manager administers the provider's coverage of, 23payment for, or formulary design for drugs necessary to 24safeguard the minor's life or health, the contract with the   10400SB1390sam001- 38 -LRB104 08735 BAB 23976 a1pharmacy benefit manager and the pharmacy benefit manager's 2activities shall be subject to Article XXXIIB of the Illinois 3Insurance Code and the authority of the Director of Insurance 4to enforce such provisions. The provider shall have all the 5rights of a plan sponsor under those provisions. 6(Source: P.A. 90-590, eff. 1-1-99.) 7    Section 30. The Unified Code of Corrections is amended by 8changing Section 3-2-2 as follows: 9    (730 ILCS 5/3-2-2)  (from Ch. 38, par. 1003-2-2)10    Sec. 3-2-2. Powers and duties of the Department. 11    (1) In addition to the powers, duties, and 12responsibilities which are otherwise provided by law, the 13Department shall have the following powers:14        (a) To accept persons committed to it by the courts of 15    this State for care, custody, treatment, and 16    rehabilitation, and to accept federal prisoners and 17    noncitizens over whom the Office of the Federal Detention 18    Trustee is authorized to exercise the federal detention 19    function for limited purposes and periods of time.20        (b) To develop and maintain reception and evaluation 21    units for purposes of analyzing the custody and 22    rehabilitation needs of persons committed to it and to 23    assign such persons to institutions and programs under its 24    control or transfer them to other appropriate agencies. In   10400SB1390sam001- 39 -LRB104 08735 BAB 23976 a1    consultation with the Department of Alcoholism and 2    Substance Abuse (now the Department of Human Services), 3    the Department of Corrections shall develop a master plan 4    for the screening and evaluation of persons committed to 5    its custody who have alcohol or drug abuse problems, and 6    for making appropriate treatment available to such 7    persons; the Department shall report to the General 8    Assembly on such plan not later than April 1, 1987. The 9    maintenance and implementation of such plan shall be 10    contingent upon the availability of funds.11        (b-1) To create and implement, on January 1, 2002, a 12    pilot program to establish the effectiveness of 13    pupillometer technology (the measurement of the pupil's 14    reaction to light) as an alternative to a urine test for 15    purposes of screening and evaluating persons committed to 16    its custody who have alcohol or drug problems. The pilot 17    program shall require the pupillometer technology to be 18    used in at least one Department of Corrections facility. 19    The Director may expand the pilot program to include an 20    additional facility or facilities as he or she deems 21    appropriate. A minimum of 4,000 tests shall be included in 22    the pilot program. The Department must report to the 23    General Assembly on the effectiveness of the program by 24    January 1, 2003.25        (b-5) To develop, in consultation with the Illinois 26    State Police, a program for tracking and evaluating each   10400SB1390sam001- 40 -LRB104 08735 BAB 23976 a1    inmate from commitment through release for recording his 2    or her gang affiliations, activities, or ranks.3        (c) To maintain and administer all State correctional 4    institutions and facilities under its control and to 5    establish new ones as needed. Pursuant to its power to 6    establish new institutions and facilities, the Department 7    may, with the written approval of the Governor, authorize 8    the Department of Central Management Services to enter 9    into an agreement of the type described in subsection (d) 10    of Section 405-300 of the Department of Central Management 11    Services Law. The Department shall designate those 12    institutions which shall constitute the State Penitentiary 13    System. The Department of Juvenile Justice shall maintain 14    and administer all State youth centers pursuant to 15    subsection (d) of Section 3-2.5-20. 16        Pursuant to its power to establish new institutions 17    and facilities, the Department may authorize the 18    Department of Central Management Services to accept bids 19    from counties and municipalities for the construction, 20    remodeling, or conversion of a structure to be leased to 21    the Department of Corrections for the purposes of its 22    serving as a correctional institution or facility. Such 23    construction, remodeling, or conversion may be financed 24    with revenue bonds issued pursuant to the Industrial 25    Building Revenue Bond Act by the municipality or county. 26    The lease specified in a bid shall be for a term of not   10400SB1390sam001- 41 -LRB104 08735 BAB 23976 a1    less than the time needed to retire any revenue bonds used 2    to finance the project, but not to exceed 40 years. The 3    lease may grant to the State the option to purchase the 4    structure outright.5        Upon receipt of the bids, the Department may certify 6    one or more of the bids and shall submit any such bids to 7    the General Assembly for approval. Upon approval of a bid 8    by a constitutional majority of both houses of the General 9    Assembly, pursuant to joint resolution, the Department of 10    Central Management Services may enter into an agreement 11    with the county or municipality pursuant to such bid.12        (c-5) To build and maintain regional juvenile 13    detention centers and to charge a per diem to the counties 14    as established by the Department to defray the costs of 15    housing each minor in a center. In this subsection (c-5), 16    "juvenile detention center" means a facility to house 17    minors during pendency of trial who have been transferred 18    from proceedings under the Juvenile Court Act of 1987 to 19    prosecutions under the criminal laws of this State in 20    accordance with Section 5-805 of the Juvenile Court Act of 21    1987, whether the transfer was by operation of law or 22    permissive under that Section. The Department shall 23    designate the counties to be served by each regional 24    juvenile detention center.25        (d) To develop and maintain programs of control, 26    rehabilitation, and employment of committed persons within   10400SB1390sam001- 42 -LRB104 08735 BAB 23976 a1    its institutions.2        (d-5) To provide a pre-release job preparation program 3    for inmates at Illinois adult correctional centers. 4        (d-10) To provide educational and visitation 5    opportunities to committed persons within its institutions 6    through temporary access to content-controlled tablets 7    that may be provided as a privilege to committed persons 8    to induce or reward compliance. 9        (e) To establish a system of supervision and guidance 10    of committed persons in the community.11        (f) To establish in cooperation with the Department of 12    Transportation to supply a sufficient number of prisoners 13    for use by the Department of Transportation to clean up 14    the trash and garbage along State, county, township, or 15    municipal highways as designated by the Department of 16    Transportation. The Department of Corrections, at the 17    request of the Department of Transportation, shall furnish 18    such prisoners at least annually for a period to be agreed 19    upon between the Director of Corrections and the Secretary 20    of Transportation. The prisoners used on this program 21    shall be selected by the Director of Corrections on 22    whatever basis he deems proper in consideration of their 23    term, behavior and earned eligibility to participate in 24    such program - where they will be outside of the prison 25    facility but still in the custody of the Department of 26    Corrections. Prisoners convicted of first degree murder,   10400SB1390sam001- 43 -LRB104 08735 BAB 23976 a1    or a Class X felony, or armed violence, or aggravated 2    kidnapping, or criminal sexual assault, aggravated 3    criminal sexual abuse or a subsequent conviction for 4    criminal sexual abuse, or forcible detention, or arson, or 5    a prisoner adjudged a Habitual Criminal shall not be 6    eligible for selection to participate in such program. The 7    prisoners shall remain as prisoners in the custody of the 8    Department of Corrections and such Department shall 9    furnish whatever security is necessary. The Department of 10    Transportation shall furnish trucks and equipment for the 11    highway cleanup program and personnel to supervise and 12    direct the program. Neither the Department of Corrections 13    nor the Department of Transportation shall replace any 14    regular employee with a prisoner.15        (g) To maintain records of persons committed to it and 16    to establish programs of research, statistics, and 17    planning.18        (h) To investigate the grievances of any person 19    committed to the Department and to inquire into any 20    alleged misconduct by employees or committed persons; and 21    for these purposes it may issue subpoenas and compel the 22    attendance of witnesses and the production of writings and 23    papers, and may examine under oath any witnesses who may 24    appear before it; to also investigate alleged violations 25    of a parolee's or releasee's conditions of parole or 26    release; and for this purpose it may issue subpoenas and   10400SB1390sam001- 44 -LRB104 08735 BAB 23976 a1    compel the attendance of witnesses and the production of 2    documents only if there is reason to believe that such 3    procedures would provide evidence that such violations 4    have occurred.5        If any person fails to obey a subpoena issued under 6    this subsection, the Director may apply to any circuit 7    court to secure compliance with the subpoena. The failure 8    to comply with the order of the court issued in response 9    thereto shall be punishable as contempt of court.10        (i) To appoint and remove the chief administrative 11    officers, and administer programs of training and 12    development of personnel of the Department. Personnel 13    assigned by the Department to be responsible for the 14    custody and control of committed persons or to investigate 15    the alleged misconduct of committed persons or employees 16    or alleged violations of a parolee's or releasee's 17    conditions of parole shall be conservators of the peace 18    for those purposes, and shall have the full power of peace 19    officers outside of the facilities of the Department in 20    the protection, arrest, retaking, and reconfining of 21    committed persons or where the exercise of such power is 22    necessary to the investigation of such misconduct or 23    violations. This subsection shall not apply to persons 24    committed to the Department of Juvenile Justice under the 25    Juvenile Court Act of 1987 on aftercare release.26        (j) To cooperate with other departments and agencies   10400SB1390sam001- 45 -LRB104 08735 BAB 23976 a1    and with local communities for the development of 2    standards and programs for better correctional services in 3    this State.4        (k) To administer all moneys and properties of the 5    Department.6        (l) To report annually to the Governor on the 7    committed persons, institutions, and programs of the 8    Department.9        (l-5) (Blank).10        (m) To make all rules and regulations and exercise all 11    powers and duties vested by law in the Department.12        (n) To establish rules and regulations for 13    administering a system of sentence credits, established in 14    accordance with Section 3-6-3, subject to review by the 15    Prisoner Review Board.16        (o) To administer the distribution of funds from the 17    State Treasury to reimburse counties where State penal 18    institutions are located for the payment of assistant 19    state's attorneys' salaries under Section 4-2001 of the 20    Counties Code.21        (p) To exchange information with the Department of 22    Human Services and the Department of Healthcare and Family 23    Services for the purpose of verifying living arrangements 24    and for other purposes directly connected with the 25    administration of this Code and the Illinois Public Aid 26    Code.  10400SB1390sam001- 46 -LRB104 08735 BAB 23976 a1        (q) To establish a diversion program.2        The program shall provide a structured environment for 3    selected technical parole or mandatory supervised release 4    violators and committed persons who have violated the 5    rules governing their conduct while in work release. This 6    program shall not apply to those persons who have 7    committed a new offense while serving on parole or 8    mandatory supervised release or while committed to work 9    release.10        Elements of the program shall include, but shall not 11    be limited to, the following:12            (1) The staff of a diversion facility shall 13        provide supervision in accordance with required 14        objectives set by the facility.15            (2) Participants shall be required to maintain 16        employment.17            (3) Each participant shall pay for room and board 18        at the facility on a sliding-scale basis according to 19        the participant's income.20            (4) Each participant shall:21                (A) provide restitution to victims in 22            accordance with any court order;23                (B) provide financial support to his 24            dependents; and25                (C) make appropriate payments toward any other 26            court-ordered obligations.  10400SB1390sam001- 47 -LRB104 08735 BAB 23976 a1            (5) Each participant shall complete community 2        service in addition to employment.3            (6) Participants shall take part in such 4        counseling, educational, and other programs as the 5        Department may deem appropriate.6            (7) Participants shall submit to drug and alcohol 7        screening.8            (8) The Department shall promulgate rules 9        governing the administration of the program.10        (r) To enter into intergovernmental cooperation 11    agreements under which persons in the custody of the 12    Department may participate in a county impact 13    incarceration program established under Section 3-6038 or 14    3-15003.5 of the Counties Code.15        (r-5) (Blank).16        (r-10) To systematically and routinely identify with 17    respect to each streetgang active within the correctional 18    system: (1) each active gang; (2) every existing 19    inter-gang affiliation or alliance; and (3) the current 20    leaders in each gang. The Department shall promptly 21    segregate leaders from inmates who belong to their gangs 22    and allied gangs. "Segregate" means no physical contact 23    and, to the extent possible under the conditions and space 24    available at the correctional facility, prohibition of 25    visual and sound communication. For the purposes of this 26    paragraph (r-10), "leaders" means persons who:  10400SB1390sam001- 48 -LRB104 08735 BAB 23976 a1            (i) are members of a criminal streetgang;2            (ii) with respect to other individuals within the 3        streetgang, occupy a position of organizer, 4        supervisor, or other position of management or 5        leadership; and6            (iii) are actively and personally engaged in 7        directing, ordering, authorizing, or requesting 8        commission of criminal acts by others, which are 9        punishable as a felony, in furtherance of streetgang 10        related activity both within and outside of the 11        Department of Corrections.12    "Streetgang", "gang", and "streetgang related" have the 13    meanings ascribed to them in Section 10 of the Illinois 14    Streetgang Terrorism Omnibus Prevention Act.15        (s) To operate a super-maximum security institution, 16    in order to manage and supervise inmates who are 17    disruptive or dangerous and provide for the safety and 18    security of the staff and the other inmates.19        (t) To monitor any unprivileged conversation or any 20    unprivileged communication, whether in person or by mail, 21    telephone, or other means, between an inmate who, before 22    commitment to the Department, was a member of an organized 23    gang and any other person without the need to show cause or 24    satisfy any other requirement of law before beginning the 25    monitoring, except as constitutionally required. The 26    monitoring may be by video, voice, or other method of   10400SB1390sam001- 49 -LRB104 08735 BAB 23976 a1    recording or by any other means. As used in this 2    subdivision (1)(t), "organized gang" has the meaning 3    ascribed to it in Section 10 of the Illinois Streetgang 4    Terrorism Omnibus Prevention Act.5        As used in this subdivision (1)(t), "unprivileged 6    conversation" or "unprivileged communication" means a 7    conversation or communication that is not protected by any 8    privilege recognized by law or by decision, rule, or order 9    of the Illinois Supreme Court.10        (u) To establish a Women's and Children's Pre-release 11    Community Supervision Program for the purpose of providing 12    housing and services to eligible female inmates, as 13    determined by the Department, and their newborn and young 14    children.15        (u-5) To issue an order, whenever a person committed 16    to the Department absconds or absents himself or herself, 17    without authority to do so, from any facility or program 18    to which he or she is assigned. The order shall be 19    certified by the Director, the Supervisor of the 20    Apprehension Unit, or any person duly designated by the 21    Director, with the seal of the Department affixed. The 22    order shall be directed to all sheriffs, coroners, and 23    police officers, or to any particular person named in the 24    order. Any order issued pursuant to this subdivision 25    (1)(u-5) shall be sufficient warrant for the officer or 26    person named in the order to arrest and deliver the   10400SB1390sam001- 50 -LRB104 08735 BAB 23976 a1    committed person to the proper correctional officials and 2    shall be executed the same as criminal process. 3        (u-6) To appoint a point of contact person who shall 4    receive suggestions, complaints, or other requests to the 5    Department from visitors to Department institutions or 6    facilities and from other members of the public.7        (v) To do all other acts necessary to carry out the 8    provisions of this Chapter.9    (2) The Department of Corrections shall by January 1, 101998, consider building and operating a correctional facility 11within 100 miles of a county of over 2,000,000 inhabitants, 12especially a facility designed to house juvenile participants 13in the impact incarceration program.14    (3) When the Department lets bids for contracts for 15medical services to be provided to persons committed to 16Department facilities by a health maintenance organization, 17medical service corporation, or other health care provider, 18the bid may only be let to a health care provider that has 19obtained an irrevocable letter of credit or performance bond 20issued by a company whose bonds have an investment grade or 21higher rating by a bond rating organization.22    (3.5) If the Department has a contract with a pharmacy 23benefit manager or a contract with an insurance company, 24health maintenance organization, limited health service 25organization, administrative services organization, or any 26other managed care entity or health insurance issuer where a   10400SB1390sam001- 51 -LRB104 08735 BAB 23976 a1pharmacy benefit manager administers the provider's coverage 2of, payment for, or formulary design for drugs necessary to 3safeguard the minor's life or health, the contract with the 4pharmacy benefit manager and the pharmacy benefit manager's 5activities shall be subject to Article XXXIIB of the Illinois 6Insurance Code and the authority of the Director of Insurance 7to enforce such provisions. The provider shall have all the 8rights of a plan sponsor under those provisions. 9    (4) When the Department lets bids for contracts for food 10or commissary services to be provided to Department 11facilities, the bid may only be let to a food or commissary 12services provider that has obtained an irrevocable letter of 13credit or performance bond issued by a company whose bonds 14have an investment grade or higher rating by a bond rating 15organization.16    (5) On and after the date 6 months after August 16, 2013 17(the effective date of Public Act 98-488), as provided in the 18Executive Order 1 (2012) Implementation Act, all of the 19powers, duties, rights, and responsibilities related to State 20healthcare purchasing under this Code that were transferred 21from the Department of Corrections to the Department of 22Healthcare and Family Services by Executive Order 3 (2005) are 23transferred back to the Department of Corrections; however, 24powers, duties, rights, and responsibilities related to State 25healthcare purchasing under this Code that were exercised by 26the Department of Corrections before the effective date of   10400SB1390sam001- 52 -LRB104 08735 BAB 23976 a1Executive Order 3 (2005) but that pertain to individuals 2resident in facilities operated by the Department of Juvenile 3Justice are transferred to the Department of Juvenile Justice. 4    (6) The Department of Corrections shall provide lactation 5or nursing mothers rooms for personnel of the Department. The 6rooms shall be provided in each facility of the Department 7that employs nursing mothers. Each individual lactation room 8must: 9        (i) contain doors that lock; 10        (ii) have an "Occupied" sign for each door; 11        (iii) contain electrical outlets for plugging in 12    breast pumps; 13        (iv) have sufficient lighting and ventilation; 14        (v) contain comfortable chairs; 15        (vi) contain a countertop or table for all necessary 16    supplies for lactation; 17        (vii) contain a wastebasket and chemical cleaners to 18    wash one's hands and to clean the surfaces of the 19    countertop or table; 20        (viii) have a functional sink; 21        (ix) have a minimum of one refrigerator for storage of 22    the breast milk; and 23        (x) receive routine daily maintenance. 24(Source: P.A. 102-350, eff. 8-13-21; 102-535, eff. 1-1-22; 25102-538, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1030, eff. 265-27-22; 103-834, eff. 1-1-25.)   10400SB1390sam001- 53 -LRB104 08735 BAB 23976 a1    Section 35. The County Jail Act is amended by changing 2Section 17 as follows: 3    (730 ILCS 125/17)  (from Ch. 75, par. 117)4    Sec. 17. Bedding, clothing, fuel, and medical aid; 5reimbursement for medical expenses. The Warden of the jail 6shall furnish necessary bedding, clothing, fuel, and medical 7services for all committed persons under his charge, and keep 8an accurate account of the same. When services that result in 9qualified medical expenses are required by any person held in 10custody, the county, private hospital, physician or any public 11agency which provides such services shall be entitled to 12obtain reimbursement from the county for the cost of such 13services. The county board of a county may adopt an ordinance 14or resolution providing for reimbursement for the cost of 15those services at the Department of Healthcare and Family 16Services' rates for medical assistance. To the extent that 17such person is reasonably able to pay for such care, including 18reimbursement from any insurance program or from other medical 19benefit programs available to such person, he or she shall 20reimburse the county or arresting authority. If such person 21has already been determined eligible for medical assistance 22under the Illinois Public Aid Code at the time the person is 23detained, the cost of such services, to the extent such cost 24exceeds $500, shall be reimbursed by the Department of   10400SB1390sam001- 54 -LRB104 08735 BAB 23976 a1Healthcare and Family Services under that Code. A 2reimbursement under any public or private program authorized 3by this Section shall be paid to the county or arresting 4authority to the same extent as would have been obtained had 5the services been rendered in a non-custodial environment.6    The sheriff or his or her designee may cause an 7application for medical assistance under the Illinois Public 8Aid Code to be completed for an arrestee who is a hospital 9inpatient. If such arrestee is determined eligible, he or she 10shall receive medical assistance under the Code for hospital 11inpatient services only. An arresting authority shall be 12responsible for any qualified medical expenses relating to the 13arrestee until such time as the arrestee is placed in the 14custody of the sheriff. However, the arresting authority shall 15not be so responsible if the arrest was made pursuant to a 16request by the sheriff. When medical expenses are required by 17any person held in custody, the county shall be entitled to 18obtain reimbursement from the County Jail Medical Costs Fund 19to the extent moneys are available from the Fund. To the extent 20that the person is reasonably able to pay for that care, 21including reimbursement from any insurance program or from 22other medical benefit programs available to the person, he or 23she shall reimburse the county.24    For the purposes of this Section, "arresting authority" 25means a unit of local government, other than a county, which 26employs peace officers and whose peace officers have made the   10400SB1390sam001- 55 -LRB104 08735 BAB 23976 a1arrest of a person. For the purposes of this Section, 2"qualified medical expenses" include medical and hospital 3services but do not include (i) expenses incurred for medical 4care or treatment provided to a person on account of a 5self-inflicted injury incurred prior to or in the course of an 6arrest, (ii) expenses incurred for medical care or treatment 7provided to a person on account of a health condition of that 8person which existed prior to the time of his or her arrest, or 9(iii) expenses for hospital inpatient services for arrestees 10enrolled for medical assistance under the Illinois Public Aid 11Code.12    If a jail or a unit of local government operating the jail 13has a contract with a pharmacy benefit manager or a contract 14with an insurance company, health maintenance organization, 15limited health service organization, administrative services 16organization, or any other managed care organization or health 17insurance issuer where a pharmacy benefit manager administers 18coverage of, payment for, or formulary design for drugs 19necessary to safeguard the life or health of any person in 20custody, that contract and the pharmacy benefit manager's 21activities shall be subject to Article XXXIIB of the Illinois 22Insurance Code and the authority of the Director of Insurance 23to enforce such provisions. The jail or unit of local 24government shall have all the rights of a plan sponsor under 25those provisions. 26(Source: P.A. 103-745, eff. 1-1-25.)   10400SB1390sam001- 56 -LRB104 08735 BAB 23976 a1    Section 99. Effective date. This Act takes effect on 2January 1, 2026, except that this Section and the changes to 3Section 513b3 of the Illinois Insurance Code take effect upon 4becoming law.".